delta.rank,pval,level,nseqs,term,name,p.adj
0,1.89E-06,2,9,GO:0042177,negative regulation of protein catabolic process,0
0,2.07E-06,4,6,GO:0032435;GO:1901799;GO:2000059;GO:1903051;GO:1903363;GO:0007130;GO:0070193,negative regulation of proteasomal protein catabolic process,0
0,2.49E-06,6,34,GO:0032434;GO:2000058,regulation of ubiquitin-dependent protein catabolic process,0
0,5.47E-06,2,63,GO:0042176,regulation of protein catabolic process,0
0,5.63E-06,2,8,GO:0042771;GO:0072332,intrinsic apoptotic signaling pathway by p53 class mediator,0
0,5.63E-06,4,8,GO:0071816;GO:0045048,tail-anchored membrane protein insertion into ER membrane,0
0,6.35E-06,4,48,GO:0090150,establishment of protein localization to membrane,0
0,7.75E-06,5,36,GO:0045665,negative regulation of neuron differentiation,0
0,8.33E-06,3,9,GO:0070059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,0
0,8.52E-06,2,42,GO:0061136;GO:1903050;GO:1903362,regulation of cellular protein catabolic process,0
0,1.09E-05,3,18,GO:0000381,regulation of alternative mRNA splicing,0
0,1.17E-05,2,10,GO:0070192,chromosome organization involved in meiotic cell cycle,0.004166667
0,1.39E-05,3,14,GO:0031330;GO:0009895,negative regulation of catabolic process,0.003846154
0,1.59E-05,3,11,GO:0008630,intrinsic apoptotic signaling pathway in response to DNA damage,0.006666667
0,1.59E-05,4,11,GO:0045861,negative regulation of proteolysis,0.006666667
0,1.99E-05,2,38,GO:1903046,meiotic cell cycle process,0.009375
0,2.02E-05,2,104,GO:0031329;GO:0009894,regulation of catabolic process,0.008823529
0,2.09E-05,2,12,GO:0051205,protein insertion into membrane,0.008333333
0,4.14E-05,4,15,GO:0030324,lung development,0.0075
0,4.14E-05,5,15,GO:0097193;GO:0097190,intrinsic apoptotic signaling pathway,0.0075
0,5.45E-05,2,18,GO:0010771;GO:0010977;GO:0031345,negative regulation of neuron projection development,0.007142857
0,7.04E-05,2,73,GO:0072657,protein localization to membrane,0.009090909
0,0.000181087,2,25,GO:0072331,signal transduction by p53 class mediator,0.026086957
0,0.000188201,5,9,GO:0061002;GO:0050774;GO:0061000;GO:2000171,negative regulation of dendritic spine morphogenesis,0.027083333
0,0.000228868,6,8,GO:0000245,spliceosomal complex assembly,0.03
0,0.000229545,3,95,GO:0032269;GO:0051248,negative regulation of protein metabolic process,0.032692308
0,0.000258054,2,39,GO:0007420,brain development,0.035185185
0,0.000271514,4,34,GO:0016573;GO:0018393;GO:0018394,internal peptidyl-lysine acetylation,0.035714286
0,0.000279213,3,69,GO:0050768;GO:0010721;GO:0051961,negative regulation of nervous system development,0.034482759
0,0.000332854,4,7,GO:0006620,posttranslational protein targeting to endoplasmic reticulum membrane,0.036666667
0,0.000370122,2,11,GO:0010508,positive regulation of autophagy,0.037096774
0,0.00037271,2,24,GO:0007033,vacuole organization,0.0359375
0,0.000382133,2,273,GO:0022402,cell cycle process,0.036363636
0,0.00049071,3,91,GO:0030162,regulation of proteolysis,0.052941176
0,0.000494162,4,24,GO:0009069,serine family amino acid metabolic process,0.051428571
0,0.000555924,2,88,GO:0051276,chromosome organization,0.058333333
0,0.000556456,2,43,GO:0043648,dicarboxylic acid metabolic process,0.056756757
0,0.00060469,5,13,GO:0061001;GO:0060998;GO:0099175,regulation of dendritic spine development,0.059210526
0,0.000607628,1,324,GO:0022414,reproductive process,0.058974359
0,0.000749068,2,112,GO:0045596,negative regulation of cell differentiation,0.07875
0,0.000781134,2,58,GO:0010769,regulation of cell morphogenesis involved in differentiation,0.081707317
0,0.000785905,7,8,GO:0006544,glycine metabolic process,0.080952381
0,0.000792218,4,95,GO:0007283;GO:0048232,male gamete generation,0.079069767
0,0.000827963,5,11,GO:0051893;GO:0090109;GO:1903391;GO:1901888,regulation of adherens junction organization,0.077272727
0,0.000914514,5,44,GO:0048024;GO:0043484;GO:0050684,regulation of mRNA processing,0.087777778
0,0.0009346,6,15,GO:1905809,negative regulation of synapse organization,0.088043478
0,0.00093796,2,44,GO:0034976,response to endoplasmic reticulum stress,0.086170213
0,0.000946029,5,5,GO:0030422;GO:0070918;GO:0031050,production of small RNA involved in gene silencing by RNA,0.084375
0,0.000988391,3,49,GO:0006475;GO:0006473;GO:0043543,protein acylation,0.089795918
0,0.00114447,3,13,GO:0045047;GO:0072599;GO:0070972,protein targeting to ER,0.104
0,0.001168566,2,16,GO:0010506,regulation of autophagy,0.103921569
0,0.001191688,4,44,GO:0050821;GO:0031647,regulation of protein stability,0.104807692
0,0.001318244,2,14,GO:0042060,wound healing,0.111320755
0,0.001454782,6,4,GO:0045745,positive regulation of G protein-coupled receptor signaling pathway,0.119444444
0,0.001475761,2,128,GO:0010975;GO:0045664;GO:0120035;GO:0031344,regulation of neuron differentiation,0.118181818
0,0.001653329,2,101,GO:0022604,regulation of cell morphogenesis,0.130357143
0,0.001730955,6,60,GO:0031331;GO:0009896,positive regulation of catabolic process,0.135087719
0,0.001794375,2,5,GO:0006020,inositol metabolic process,0.137931034
0,0.001800227,7,26,GO:0006555;GO:0009086;GO:0000097;GO:0009067,aspartate family amino acid biosynthetic process,0.13559322
0,0.001841164,3,126,GO:1901605,alpha-amino acid metabolic process,0.135833333
0,0.001896192,2,17,GO:0001952,regulation of cell-matrix adhesion,0.139344262
0,0.00222072,2,5,GO:0008584,male gonad development,0.160483871
0,0.002274336,2,54,GO:1903311,regulation of mRNA metabolic process,0.16031746
0,0.002370791,3,8,GO:0000278,mitotic cell cycle,0.1640625
0,0.002393367,2,5,GO:0007406;GO:2000647,negative regulation of neuroblast proliferation,0.158208955
0,0.002393367,2,5,GO:0048311,mitochondrion distribution,0.158208955
0,0.002393367,5,5,GO:2000172;GO:0022029;GO:0021885,telencephalon cell migration,0.158208955
0,0.002460736,4,50,GO:0001822,kidney development,0.1625
0,0.002464164,2,133,GO:0048609;GO:0007276,multicellular organismal reproductive process,0.160144928
0,0.002554352,2,60,GO:0022618;GO:0071826,ribonucleoprotein complex subunit organization,0.160714286
0,0.002760623,3,10,GO:0030718,germ-line stem cell population maintenance,0.16971831
0,0.002783206,2,21,GO:0006612,protein targeting to membrane,0.168055556
0,0.002819732,2,93,GO:0051707,response to other organism,0.167123288
0,0.002883561,2,8,GO:0006105,succinate metabolic process,0.168918919
0,0.003023963,4,6,GO:0009258;GO:0009256;GO:0009397;GO:0043649;GO:0042219;GO:0042560,dicarboxylic acid catabolic process,0.171333333
0,0.003269596,4,23,GO:0010810,regulation of cell-substrate adhesion,0.181578947
0,0.003302447,3,54,GO:1901607;GO:0008652,cellular amino acid biosynthetic process,0.181818182
0,0.003362989,2,39,GO:0031396;GO:1903320,regulation of protein modification by small protein conjugation or removal,0.183333333
0,0.003368319,2,33,GO:0009798,axis specification,0.18164557
0,0.003656283,2,40,GO:0050807,regulation of synapse organization,0.195625
0,0.003672158,2,11,GO:0000724;GO:0000725,double-strand break repair via homologous recombination,0.193209877
0,0.003680416,2,40,GO:0045732,positive regulation of protein catabolic process,0.191463415
0,0.00374588,2,4,GO:0031573,intra-S DNA damage checkpoint,0.190963855
0,0.00378077,2,25,GO:0001707,mesoderm formation,0.189880952
0,0.003899017,3,386,GO:0010629;GO:0010605;GO:0009892,negative regulation of metabolic process,0.192352941
0,0.003980547,2,441,GO:0032268;GO:0051246,regulation of protein metabolic process,0.194767442
0,0.004001046,2,76,GO:0018205,peptidyl-lysine modification,0.193678161
0,0.004238676,3,30,GO:0000096,sulfur amino acid metabolic process,0.207954545
0,0.004371037,2,964,GO:0048523;GO:0048519,negative regulation of biological process,0.214606742
0,0.004516377,3,10,GO:0046532;GO:0046533,regulation of photoreceptor cell differentiation,0.219444444
0,0.004544318,3,245,GO:0017144,drug metabolic process,0.218131868
0,0.004560232,2,26,GO:0050773;GO:0048814,regulation of dendrite development,0.216304348
0,0.004588284,6,28,GO:0006893;GO:0098876;GO:0043001;GO:0061951;GO:0072659;GO:1990778,Golgi to plasma membrane transport,0.214516129
0,0.004604425,2,164,GO:0051093,negative regulation of developmental process,0.213297872
0,0.00463715,5,5,GO:0045910,negative regulation of DNA recombination,0.213157895
0,0.004661925,3,562,GO:1901575;GO:0009056;GO:0044248,catabolic process,0.213541667
0,0.004712781,2,23,GO:0031398;GO:1903322,positive regulation of protein modification by small protein conjugation or removal,0.215463918
0,0.004865029,2,25,GO:0008340,determination of adult lifespan,0.218877551
0,0.004897572,2,7,GO:0035640,exploration behavior,0.2155
0,0.004897572,2,7,GO:2000178,negative regulation of neural precursor cell proliferation,0.2155
0,0.004992249,3,165,GO:0050767;GO:0060284;GO:0051960,regulation of nervous system development,0.217326733
0,0.004992666,2,21,GO:0042133,neurotransmitter metabolic process,0.215196078
0,0.005180235,4,37,GO:0006446,regulation of translational initiation,0.219902913
0,0.00522307,4,6,GO:0060047;GO:0003015,heart contraction,0.222115385
0,0.00551104,3,6,GO:0006268,DNA unwinding involved in DNA replication,0.233962264
0,0.00551104,5,6,GO:0007131;GO:0035825,reciprocal meiotic recombination,0.233962264
0,0.005704797,2,12,GO:0031054,pre-miRNA processing,0.239719626
0,0.005838616,4,65,GO:0043065;GO:0043068;GO:0010942,positive regulation of cell death,0.243518519
0,0.00611934,6,31,GO:0006898,receptor-mediated endocytosis,0.25733945
0,0.006320908,4,34,GO:0030177,positive regulation of Wnt signaling pathway,0.263636364
0,0.006367886,2,7,GO:0000018,regulation of DNA recombination,0.262162162
0,0.006446281,2,8,GO:0070997,neuron death,0.263839286
0,0.006496593,4,176,GO:0034613;GO:0070727,cellular macromolecule localization,0.263716814
0,0.006621816,3,35,GO:0001704,formation of primary germ layer,0.265350877
0,0.006852348,4,48,GO:0042742;GO:0009617,response to bacterium,0.275217391
0,0.006925545,2,36,GO:0010632,regulation of epithelial cell migration,0.275
0,0.006981629,3,9,GO:0009109,coenzyme catabolic process,0.273504274
0,0.007068819,2,27,GO:0006302,double-strand break repair,0.274152542
0,0.007124431,2,290,GO:0031324;GO:0051172,negative regulation of cellular metabolic process,0.272689076
0,0.007444319,2,53,GO:0015074,DNA integration,0.282916667
0,0.007676509,4,202,GO:0022603,regulation of anatomical structure morphogenesis,0.284710744
0,0.007888888,2,200,GO:0006520,cellular amino acid metabolic process,0.295081967
0,0.00789808,3,568,GO:0006996,organelle organization,0.292682927
0,0.007967813,2,456,GO:0035556,intracellular signal transduction,0.293145161
0,0.00811663,6,28,GO:0032436;GO:1901800;GO:2000060;GO:1903052;GO:1903364,positive regulation of ubiquitin-dependent protein catabolic process,0.2996
0,0.008181868,4,9,GO:0035564,regulation of kidney size,0.3
0,0.008387415,2,442,GO:0022607,cellular component assembly,0.306692913
0,0.008407275,3,10,GO:0007032,endosome organization,0.3046875
0,0.008554117,4,47,GO:0044272,sulfur compound biosynthetic process,0.307364341
0,0.008675962,5,4,GO:0007367;GO:0007365,segment polarity determination,0.30530303
0,0.008675962,5,4,GO:0035087;GO:0070922,siRNA loading onto RISC involved in RNA interference,0.30530303
0,0.008675962,2,4,GO:0042078,germ-line stem cell division,0.30530303
0,0.008839437,2,10,GO:0051053,negative regulation of DNA metabolic process,0.308646617
0,0.008868625,6,162,GO:0006511;GO:0019941;GO:0043632;GO:0051603,proteolysis involved in cellular protein catabolic process,0.307089552
0,0.009004651,4,392,GO:0051128,regulation of cellular component organization,0.310740741
0,0.009112728,3,43,GO:0009611,response to wounding,0.312132353
0,0.009150156,5,9,GO:0019509;GO:0071267;GO:0043102;GO:0071265,amino acid salvage,0.311678832
0,0.009556678,2,229,GO:0048646,anatomical structure formation involved in morphogenesis,0.32173913
0,0.009631354,4,11,GO:0032508;GO:0032392,DNA geometric change,0.321223022
0,0.009649611,5,4,GO:0006546;GO:0009071,serine family amino acid catabolic process,0.320714286
0,0.009703285,5,101,GO:0051129,negative regulation of cellular component organization,0.320921986
0,0.009743729,4,117,GO:0007186,G protein-coupled receptor signaling pathway,0.320774648
0,0.009894976,2,5,GO:0031623,receptor internalization,0.324475524
0,0.009924301,5,12,GO:0000723;GO:0032200,telomere organization,0.323611111
0,0.010096488,2,10,GO:0051646,mitochondrion localization,0.328275862
0,0.010395415,2,11,GO:0006760;GO:0046653,folic acid-containing compound metabolic process,0.33630137
0,0.010407818,4,12,GO:0044773;GO:0044774,mitotic DNA integrity checkpoint,0.334693878
0,0.010810604,3,55,GO:0098542,defense response to other organism,0.344594595
0,0.010944033,2,56,GO:0007218,neuropeptide signaling pathway,0.345973154
0,0.01123923,8,15,GO:0070536,protein K63-linked deubiquitination,0.357
0,0.011759724,2,6,GO:0021533,cell differentiation in hindbrain,0.368543046
0,0.011837128,2,28,GO:0022904,respiratory electron transport chain,0.36875
0,0.011999573,2,122,GO:0007389,pattern specification process,0.371568627
0,0.012092226,2,16,GO:0002576,platelet degranulation,0.371103896
0,0.012157519,3,423,GO:0019752;GO:0043436;GO:0006082,organic acid metabolic process,0.370322581
0,0.012182531,2,11,GO:0018105;GO:0018209,peptidyl-serine modification,0.368910256
0,0.012407675,4,4,GO:0050931,pigment cell differentiation,0.374840764
0,0.012647471,5,15,GO:0030071;GO:0010965;GO:1902099;GO:0033047;GO:1905818;GO:0033045,regulation of sister chromatid segregation,0.378164557
0,0.012764311,2,6,GO:0007279,pole cell formation,0.380503145
0,0.012851164,4,11,GO:0043046;GO:0034587,piRNA metabolic process,0.38125
0,0.012975653,2,55,GO:0006892,post-Golgi vesicle-mediated transport,0.381987578
0,0.013153183,2,287,GO:0009057;GO:0044265,macromolecule catabolic process,0.383950617
0,0.013445911,3,133,GO:0043207;GO:0009607,response to biotic stimulus,0.390490798
0,0.013588103,3,7,GO:0000045;GO:1905037,autophagosome organization,0.38969697
0,0.013588103,3,7,GO:0050771,negative regulation of axonogenesis,0.38969697
0,0.01382081,4,10,GO:0045124;GO:0046850;GO:0034103,regulation of tissue remodeling,0.393975904
0,0.014152995,3,12,GO:0007040;GO:0080171,lytic vacuole organization,0.399700599
0,0.014228948,5,159,GO:0018193,peptidyl-amino acid modification,0.398809524
0,0.014432611,4,12,GO:0000186,activation of MAPKK activity,0.398529412
0,0.014432611,3,12,GO:0008277,regulation of G protein-coupled receptor signaling pathway,0.398529412
0,0.014897729,3,61,GO:0030111,regulation of Wnt signaling pathway,0.411403509
0,0.015042766,5,20,GO:0050727,regulation of inflammatory response,0.413662791
0,0.015116724,2,41,GO:0032886,regulation of microtubule-based process,0.413294798
0,0.015210503,2,25,GO:0019827;GO:0098727,stem cell population maintenance,0.411206897
0,0.015369956,3,131,GO:1903047,mitotic cell cycle process,0.414
0,0.0154054,2,42,GO:0051187,cofactor catabolic process,0.412784091
0,0.015417272,4,427,GO:0016192,vesicle-mediated transport,0.410734463
0,0.015511895,2,202,GO:0051241,negative regulation of multicellular organismal process,0.412359551
0,0.015617428,2,84,GO:0006310,DNA recombination,0.412011173
0,0.015759751,4,9,GO:0043087;GO:0048013,regulation of GTPase activity,0.413611111
0,0.015846398,5,64,GO:0006605,protein targeting,0.413812155
0,0.016027671,3,17,GO:0043094,cellular metabolic compound salvage,0.415659341
0,0.016098084,2,20,GO:0051983,regulation of chromosome segregation,0.414754098
0,0.016404056,4,7,GO:0042135,neurotransmitter catabolic process,0.420380435
0,0.016461781,2,112,GO:0009790,embryo development,0.42027027
0,0.016515282,2,194,GO:0009605,response to external stimulus,0.419354839
0,0.016748313,5,21,GO:0009411,response to UV,0.42486631
0,0.017138565,5,9,GO:0030516;GO:0061387,regulation of extent of cell growth,0.431382979
0,0.017833082,3,16,GO:0006306;GO:0006305;GO:0044728;GO:0006304,DNA modification,0.447089947
0,0.018009102,4,256,GO:0045595,regulation of cell differentiation,0.448421053
0,0.01801092,2,23,GO:0007093,mitotic cell cycle checkpoint,0.446073298
0,0.018451139,4,11,GO:0090084;GO:0090083,regulation of inclusion body assembly,0.454427083
0,0.018602645,2,9,GO:0017145,stem cell division,0.454404145
0,0.018623788,7,24,GO:0000077;GO:0031570,DNA integrity checkpoint,0.45257732
0,0.018961886,3,28,GO:0045055,regulated exocytosis,0.456923077
0,0.019179073,2,115,GO:0022412,cellular process involved in reproduction in multicellular organism,0.463520408
0,0.019222768,3,48,GO:0001505,regulation of neurotransmitter levels,0.46142132
0,0.019252378,4,57,GO:0042737,drug catabolic process,0.45959596
0,0.019396448,2,14,GO:0060688,regulation of morphogenesis of a branching structure,0.45775
0,0.019396448,4,14,GO:1902692;GO:0072091;GO:2000177,regulation of neural precursor cell proliferation,0.45775
0,0.019509438,3,91,GO:0006790,sulfur compound metabolic process,0.456467662
0,0.019606102,2,6,GO:0071260,cellular response to mechanical stimulus,0.456930693
0,0.020391484,6,27,GO:0033044,regulation of chromosome organization,0.472660099
0,0.021170278,2,51,GO:0016049,cell growth,0.4875
0,0.02124237,2,37,GO:0050770,regulation of axonogenesis,0.486829268
0,0.021275667,2,16,GO:0042558,pteridine-containing compound metabolic process,0.484708738
0,0.02151313,6,29,GO:0007088;GO:0051783,regulation of nuclear division,0.486714976
0,0.021818905,5,127,GO:0045786,negative regulation of cell cycle,0.491105769
0,0.022164092,2,18,GO:0120032;GO:0060491,regulation of plasma membrane bounded cell projection assembly,0.502631579
0,0.022481636,7,5,GO:0006824,cobalt ion transport,0.507619048
0,0.022654421,4,7,GO:0061448;GO:0060612,connective tissue development,0.508530806
0,0.022841979,1,111,GO:0040007,growth,0.511084906
0,0.023416431,4,134,GO:0046394;GO:0016053,carboxylic acid biosynthetic process,0.521126761
0,0.023566248,2,38,GO:0030168,platelet activation,0.521962617
0,0.023656679,2,154,GO:0016055;GO:1905114,Wnt signaling pathway,0.520697674
0,0.023833231,2,13,GO:0021953,central nervous system neuron differentiation,0.522916667
0,0.023842926,3,236,GO:0006281;GO:0006974,cellular response to DNA damage stimulus,0.520506912
0,0.023922076,4,39,GO:0007265,Ras protein signal transduction,0.519266055
0,0.025426052,3,14,GO:0043112,receptor metabolic process,0.549086758
0,0.025643282,2,8,GO:0006534,cysteine metabolic process,0.551136364
0,0.025939827,2,51,GO:0006575,cellular modified amino acid metabolic process,0.554298643
0,0.026046865,2,38,GO:0009416,response to light stimulus,0.553603604
0,0.026073894,2,17,GO:0048640,negative regulation of developmental growth,0.551569507
0,0.026228538,2,14,GO:0045947,negative regulation of translational initiation,0.553348214
0,0.026263804,1,1028,GO:0032501,multicellular organismal process,0.551555556
0,0.02629159,2,426,GO:0007275,multicellular organism development,0.549336283
0,0.026373098,3,5,GO:0001658,branching involved in ureteric bud morphogenesis,0.543231441
0,0.026373098,3,5,GO:0008585,female gonad development,0.543231441
0,0.026373098,2,5,GO:0060563,neuroepithelial cell differentiation,0.543231441
0,0.026383143,5,55,GO:0007050,cell cycle arrest,0.541086957
0,0.026502655,2,39,GO:0071103,DNA conformation change,0.54047619
0,0.027387662,6,41,GO:1901990;GO:1901987,regulation of cell cycle phase transition,0.552155172
0,0.027388985,5,106,GO:0048193,Golgi vesicle transport,0.549785408
0,0.027627607,3,366,GO:0006915;GO:0012501;GO:0008219,cell death,0.55
0,0.027964153,2,28,GO:0031047,gene silencing by RNA,0.552978723
0,0.028272285,4,860,GO:0071702;GO:0071705;GO:0015031;GO:0015833;GO:0045184;GO:0042886;GO:0008104;GO:0033036,organic substance transport,0.556779661
0,0.028651289,3,44,GO:0045930;GO:0010948,negative regulation of mitotic cell cycle,0.558860759
0,0.028974112,2,12,GO:0007205,protein kinase C-activating G protein-coupled receptor signaling pathway,0.56197479
0,0.029056121,2,45,GO:0000075,cell cycle checkpoint,0.560460251
0,0.029201522,3,4,GO:0033700,phospholipid efflux,0.55661157
0,0.029201522,5,4,GO:0050663,cytokine secretion,0.55661157
0,0.029201522,5,4,GO:0065005;GO:0071825,protein-lipid complex assembly,0.55661157
0,0.029209373,3,97,GO:0006066,alcohol metabolic process,0.55204918
0,0.029209373,2,97,GO:0007163,establishment or maintenance of cell polarity,0.55204918
0,0.030020393,2,17,GO:0048675;GO:1990138,axon extension,0.558571429
0,0.030025971,4,5,GO:0042710;GO:0000128;GO:0001403;GO:0036267;GO:0070783;GO:0044182;GO:0030447;GO:0007124,invasive growth in response to glucose limitation,0.556300813
0,0.030093625,2,58,GO:0090287,regulation of cellular response to growth factor stimulus,0.5548583
0,0.03066568,5,28,GO:0006342;GO:0045814;GO:0097549;GO:0034401,chromatin organization involved in regulation of transcription,0.561491935
0,0.030955304,3,16,GO:0007349,cellularization,0.562449799
0,0.030999218,4,32,GO:0009066,aspartate family amino acid metabolic process,0.561
0,0.03117683,4,33,GO:0030182,neuron differentiation,0.561155378
0,0.031343214,3,6,GO:0002067,glandular epithelial cell differentiation,0.562103175
0,0.03162261,3,59,GO:0046395;GO:0016054,organic acid catabolic process,0.565217391
0,0.031733876,2,19,GO:0008406,gonad development,0.56496063
0,0.032477852,2,788,GO:0006950,response to stress,0.573333333
0,0.033489327,2,7,GO:0071108,protein K48-linked deubiquitination,0.5890625
0,0.033501497,2,36,GO:0043414;GO:0032259,macromolecule methylation,0.587159533
0,0.034200982,4,19,GO:0007528,neuromuscular junction development,0.595930233
0,0.034219358,4,57,GO:0046777,protein autophosphorylation,0.594015444
0,0.034271327,1,270,GO:0051704,multi-organism process,0.592115385
0,0.035234917,3,141,GO:0044087,regulation of cellular component biogenesis,0.603256705
0,0.035259098,2,86,GO:0016999,antibiotic metabolic process,0.601145038
0,0.035404807,5,64,GO:0007346,regulation of mitotic cell cycle,0.602661597
0,0.035595469,2,25,GO:0033013,tetrapyrrole metabolic process,0.602840909
0,0.035640056,5,127,GO:0006897;GO:0098657,import into cell,0.600943396
0,0.036149547,4,5,GO:0032365,intracellular lipid transport,0.607518797
0,0.036402495,2,778,GO:0044281,small molecule metabolic process,0.60917603
0,0.036914606,2,7,GO:0006516,glycoprotein catabolic process,0.616044776
0,0.037026903,7,12,GO:0009070,serine family amino acid biosynthetic process,0.615427509
0,0.037155175,2,8,GO:0043152,induction of bacterial agglutination,0.615925926
0,0.03743176,2,37,GO:0040029,regulation of gene expression,
0,0.037597151,6,46,GO:0006099;GO:0006101;GO:0072350,tricarboxylic acid metabolic process,0.618933824
0,0.038329937,2,7,GO:0006930,substrate-dependent cell migration,
0,0.038442016,2,100,GO:0001775,cell activation,0.625182482
0,0.038670607,2,82,GO:0003002,regionalization,0.625272727
0,0.038976658,3,79,GO:0010564,regulation of cell cycle process,0.62826087
0,0.039593788,8,6,GO:0000289,nuclear-transcribed mRNA poly(A) tail shortening,0.63465704
0,0.039670426,3,201,GO:0051186,cofactor metabolic process,0.633273381
0,0.040073845,2,41,GO:0009615,response to virus,0.634767025
0,0.040227732,5,67,GO:0032147,activation of protein kinase activity,0.634642857
0,0.04102256,2,25,GO:0030308,negative regulation of cell growth,0.643950178
0,0.041232641,2,7,GO:0098630,aggregation of unicellular organisms,0.643439716
0,0.042390943,3,14,GO:0071214;GO:0104004,cellular response to abiotic stimulus,0.655123675
0,0.042727291,2,53,GO:0016458,gene silencing,0.657570423
0,0.043285413,4,123,GO:0051270;GO:0040012,regulation of locomotion,0.663508772
0,0.043393774,3,198,GO:0044283,small molecule biosynthetic process,0.662062937
0,0.043468323,2,7,GO:0016180,snRNA processing,0.660801394
0,0.04401792,2,25,GO:0001816,cytokine production,0.665625
0,0.044620026,4,26,GO:0019751,polyol metabolic process,0.670934256
0,0.044855512,2,65,GO:0006887,exocytosis,0.670689655
0,0.04567945,3,9,GO:0051145,smooth muscle cell differentiation,0.679209622
0,0.045891521,2,26,GO:0048813,dendrite morphogenesis,0.679280822
0,0.046323289,2,170,GO:0016567;GO:0032446,protein modification by small protein conjugation,0.682081911
0,0.046546631,3,111,GO:0006417;GO:0010608;GO:0034248,posttranscriptional regulation of gene expression,0.683503401
0,0.047192667,2,75,GO:0048589,developmental growth,0.689661017
0,0.04754764,3,16,GO:0006750;GO:0019184,nonribosomal peptide biosynthetic process,0.690878378
0,0.048345242,2,9,GO:0001778,plasma membrane repair,0.697306397
0,0.048383512,2,108,GO:0032940;GO:0046903,secretion,0.695805369
0,0.049323314,3,32,GO:0048588,developmental cell growth,0.702508361
0,0.050272977,2,10,GO:0002065,columnar/cuboidal epithelial cell differentiation,0.711
0,0.050501147,4,4,GO:0048821;GO:0061515,myeloid cell development,0.711295681
0,0.051491221,2,202,GO:0051726,regulation of cell cycle,0.718211921
0,0.051492663,2,24,GO:0006541,glutamine metabolic process,0.715841584
0,0.051587537,2,221,GO:0042981;GO:0043067;GO:0010941,regulation of cell death,0.714309211
0,0.052504976,3,18,GO:0009612,response to mechanical stimulus,0.723114754
0,0.053346766,2,215,GO:0070647,protein modification by small protein conjugation or removal,0.728921569
0,0.053649182,2,12,GO:0019730;GO:0019731,antimicrobial humoral response,0.729641694
0,0.054414878,2,8,GO:0010591;GO:1902743,regulation of lamellipodium organization,0.735876623
0,0.054444891,5,3396,unknown,unknown,0.733656958
0,0.054588071,3,37,GO:0060560,developmental growth involved in morphogenesis,0.731612903
0,0.055602624,2,6,GO:0032092,positive regulation of protein binding,0.738424437
0,0.056191107,2,8,GO:0015914;GO:0015748,phospholipid transport,0.738498403
0,0.056191107,2,8,GO:0055081,anion homeostasis,0.738498403
0,0.056295541,3,177,GO:0030030,cell projection organization,0.737420382
0,0.05698838,2,738,GO:0065008,regulation of biological quality,0.74015873
0,0.057011697,2,175,GO:1901565,organonitrogen compound catabolic process,0.737974684
0,0.058225981,2,62,GO:0045862,positive regulation of proteolysis,0.74873817
0,0.058888525,5,21,GO:0045022;GO:0098927,early endosome to late endosome transport,0.753616352
0,0.058937451,2,324,GO:2000026,regulation of multicellular organismal development,0.751567398
0,0.059192906,3,12,GO:0040036,regulation of fibroblast growth factor receptor signaling pathway,0.7515625
0,0.059874171,8,6,GO:0031146,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,0.755451713
0,0.06014032,2,138,GO:0033043,regulation of organelle organization,0.755745342
0,0.060339576,2,10,GO:0016073,snRNA metabolic process,0.755417957
0,0.060799561,2,65,GO:0008203;GO:0016125;GO:1902652,sterol metabolic process,0.75787037
0,0.061851956,4,22,GO:0006749,glutathione metabolic process,0.762883436
0,0.061851956,2,22,GO:0071496,cellular response to external stimulus,0.762883436
0,0.062481431,2,111,GO:0045860;GO:0033674;GO:0051347,positive regulation of transferase activity,0.767125382
0,0.062612721,4,9,GO:0010888;GO:1905953;GO:0010891;GO:0010889;GO:0010898;GO:0010896;GO:0050996,negative regulation of lipid localization,0.76570122
0,0.062655187,3,305,GO:0048513,animal organ development,0.763677812
0,0.062792321,3,482,GO:0051239,regulation of multicellular organismal process,0.762878788
0,0.063433445,3,35,GO:0009063;GO:1901606,cellular amino acid catabolic process,0.767371601
0,0.06346018,2,199,GO:0034660,ncRNA metabolic process,0.765210843
0,0.063606323,2,5,GO:0009737,response to abscisic acid,0.763513514
0,0.064075736,2,23,GO:0042398,cellular modified amino acid biosynthetic process,0.764670659
0,0.064610185,2,11,GO:0007052,mitotic spindle organization,0.765223881
0,0.064822798,2,4,GO:0033522,histone H2A ubiquitination,0.765922619
0,0.065933438,1,116,GO:0007610,behavior,0.772551929
0,0.067078752,2,88,GO:0016042,lipid catabolic process,0.780621302
0,0.06747242,4,33,GO:0000086;GO:0044839,cell cycle G2/M phase transition,0.781268437
0,0.067533041,3,85,GO:0044282,small molecule catabolic process,0.780147059
0,0.067556304,2,736,GO:0006464;GO:0036211;GO:0044267;GO:0043412,cellular protein metabolic process,0.77829912
0,0.068271999,5,6,GO:0046627;GO:1900077,negative regulation of cellular response to insulin stimulus,0.780847953
0,0.068909058,6,10,GO:0033344;GO:0030301;GO:0015918,sterol transport,0.782848837
0,0.068909058,6,10,GO:0042632;GO:0055092,sterol homeostasis,0.782848837
0,0.068925068,3,63,GO:0035023,regulation of Rho protein signal transduction,0.78057971
0,0.069518275,2,4,GO:0007193,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway,0.782803468
0,0.070754962,4,4,GO:0007004;GO:0010833,telomere maintenance via telomerase,0.79221902
0,0.072233507,2,142,GO:1901615,organic hydroxy compound metabolic process,0.8
0,0.072321137,2,13,GO:0044764,multi-organism cellular process,0.798137536
0,0.072325309,2,4,GO:0060632,regulation of microtubule-based movement,0.795857143
0,0.072573562,3,33,GO:0048666,neuron development,0.794871795
0,0.072723978,2,8,GO:0043496,regulation of protein homodimerization activity,0.793039773
0,0.073063395,7,5,GO:0043984,histone H4-K16 acetylation,0.794334278
0,0.073466368,2,72,GO:0051336,regulation of hydrolase activity,0.794491525
0,0.074263459,3,450,GO:0050793,regulation of developmental process,0.798028169
0,0.074548426,5,33,GO:0042744;GO:0017001;GO:0042743,hydrogen peroxide metabolic process,0.797331461
0,0.075082551,3,11,GO:0010883,regulation of lipid storage,0.798879552
0,0.075428348,2,71,GO:0016050,vesicle organization,0.79972067
0,0.075692297,4,7,GO:0007398,ectoderm development,0.797361111
0,0.075692297,3,7,GO:0046843,dorsal appendage formation,0.797361111
0,0.076130058,2,65,GO:0001558,regulation of cell growth,0.797783934
0,0.077191998,2,402,GO:0006259,DNA metabolic process,0.804558011
0,0.077920547,5,9,GO:0046686,response to cadmium ion,0.807575758
0,0.078849065,2,27,GO:0070936,protein K48-linked ubiquitination,0.811126374
0,0.078886797,5,7,GO:0033003,regulation of mast cell activation,0.809315068
0,0.079019912,3,108,GO:0030155,regulation of cell adhesion,0.808606557
0,0.080059931,3,518,GO:0046907;GO:0051641;GO:0051649,cellular localization,0.813623978
0,0.080246324,2,5,GO:0071894;GO:0033523;GO:0010390,histone H2B ubiquitination,0.8125
0,0.080637118,3,69,GO:0009314,response to radiation,0.814498645
0,0.080763735,2,91,GO:0046578,regulation of Ras protein signal transduction,0.813243243
0,0.08126664,2,174,GO:0016477,cell migration,0.816576819
0,0.081845607,4,26,GO:0010212,response to ionizing radiation,0.817473118
0,0.082603859,4,40,GO:0060249,anatomical structure homeostasis,0.819436997
0,0.083936863,2,18,GO:0007492,endoderm development,0.8256
0,0.083936863,2,18,GO:0042692,muscle cell differentiation,0.8256
0,0.084150637,4,9,GO:0002260;GO:0001776,leukocyte homeostasis,0.819708995
0,0.084150637,7,9,GO:0043124,negative regulation of I-kappaB kinase/NF-kappaB signaling,0.819708995
0,0.084150637,2,9,GO:0050691,regulation of defense response to virus by host,0.819708995
0,0.084346004,3,25,GO:0006730,one-carbon metabolic process,0.818469657
0,0.084681447,2,171,GO:0009628,response to abiotic stimulus,0.817894737
0,0.08484326,4,15,GO:1902850,microtubule cytoskeleton organization involved in mitosis,0.816535433
0,0.085678592,3,8,GO:0007440,foregut morphogenesis,0.809302326
0,0.085678592,4,8,GO:0008347,glial cell migration,0.809302326
0,0.085678592,3,8,GO:0010454,negative regulation of cell fate commitment,0.809302326
0,0.085678592,2,8,GO:0035265,organ growth,0.809302326
0,0.085678592,7,8,GO:0042051,compound eye photoreceptor development,0.809302326
0,0.085678592,3,8,GO:0042659,regulation of cell fate specification,0.809302326
0,0.086059013,2,5,GO:0051220,cytoplasmic sequestering of protein,0.810309278
0,0.087036831,2,91,GO:0033365;GO:0072594,protein localization to organelle,0.814910026
0,0.087446851,4,51,GO:0016579;GO:0070646,protein modification by small protein removal,0.815
0,0.088835306,3,18,GO:0001764,neuron migration,0.824168798
0,0.089533935,3,5,GO:0021756,striatum development,0.824300254
0,0.089533935,2,5,GO:0035082;GO:0001578,microtubule bundle formation,0.824300254
0,0.090544816,2,93,GO:2000145;GO:0030334,regulation of cell motility,0.830583756
0,0.091095874,1,17,GO:0098743,cell aggregation,0.833037975
0,0.092410964,2,54,GO:0044772;GO:0044770,mitotic cell cycle phase transition,0.839141414
0,0.092612827,6,10,GO:0031397;GO:1903321,negative regulation of protein modification by small protein conjugation or removal,0.838161209
0,0.092877897,6,31,GO:0051168,nuclear export,0.837562814
0,0.092889593,2,14,GO:0007266,Rho protein signal transduction,0.835463659
0,0.093555604,2,27,GO:0003013,circulatory system process,0.83975
0,0.094238705,2,123,GO:0051056,regulation of small GTPase mediated signal transduction,0.841770574
0,0.094502536,3,97,GO:0032989,cellular component morphogenesis,0.841293532
0,0.095261752,5,41,GO:0000398;GO:0000377;GO:0000375,RNA splicing,
0,0.095470086,4,9,GO:0009954,proximal/distal pattern formation,0.830929095
0,0.095470086,2,9,GO:0010623,programmed cell death involved in cell development,0.830929095
0,0.095470086,2,9,GO:0046331;GO:0045168,cell-cell signaling involved in cell fate commitment,0.830929095
0,0.095470086,3,9,GO:0048190;GO:0007450;GO:0035222;GO:0007447,wing disc pattern formation,0.830929095
0,0.095470086,3,9,GO:0110111,negative regulation of animal organ morphogenesis,0.830929095
0,0.095470086,2,9,GO:2000736,regulation of stem cell differentiation,0.830929095
0,0.095639073,2,241,GO:0048870;GO:0040011,locomotion,0.829512195
0,0.096060616,4,26,GO:0006767,water-soluble vitamin metabolic process,0.828345499
0,0.096095429,4,58,GO:0007268;GO:0098916;GO:0099537;GO:0099536,trans-synaptic signaling,0.826456311
0,0.097418937,2,753,GO:0009966;GO:0010646;GO:0023051;GO:0048583,regulation of response to stimulus,0.831961259
0,0.0979249,4,29,GO:0006986;GO:0035966,response to topologically incorrect protein,0.831763285
0,0.098309334,2,10,GO:0034312;GO:0046173,polyol biosynthetic process,0.831686747
0,0.098473761,3,30,GO:0032675,regulation of interleukin-6 production,0.830168269
0,0.09859511,3,15,GO:0009306;GO:0002790,peptide secretion,0.82715311
0,0.09859511,2,15,GO:0055088,lipid homeostasis,0.82715311
0,0.098879375,6,22,GO:0001657;GO:0072164;GO:0072163,mesonephric epithelium development,0.826372315
0,0.099495133,2,6,GO:0070593,dendrite self-avoidance,0.827619048
0,0.099499283,3,9,GO:0046626;GO:1900076,regulation of insulin receptor signaling pathway,0.825653207
0,0.099521038,2,56,GO:0051052,regulation of DNA metabolic process,0.823815166
0,0.100089166,2,133,GO:0043410;GO:0043408,regulation of MAPK cascade,0.825531915
0,0.100280497,3,130,GO:0034470,ncRNA processing,0.824292453
0,0.100785653,2,22,GO:0009100,glycoprotein metabolic process,0.826235294
0,0.100795421,7,6,GO:0045116,protein neddylation,0.824295775
0,0.100909917,7,11,GO:0001922;GO:0001782;GO:0045779;GO:0046851;GO:0034104;GO:2000349;GO:2000348;GO:2000352;GO:1904036;GO:2000351;GO:1904035;GO:0032703;GO:0090291;GO:0090289;GO:0034136;GO:0034122;GO:0034135;GO:0034121;GO:0034140;GO:0034139;GO:0070423;GO:0002753;GO:0035872;GO:0061043;GO:0072573;GO:0002507;GO:0031665;GO:0002832,cytoplasmic pattern recognition receptor signaling pathway,0.821378505
0,0.100909917,2,11,GO:0032715,negative regulation of interleukin-6 production,0.821378505
0,0.100971866,2,143,GO:0003006,developmental process involved in reproduction,0.81969697
0,0.101339502,3,50,GO:0035239,tube morphogenesis,0.82
0,0.102277179,2,6,GO:0007212,dopamine receptor signaling pathway,0.822337963
0,0.102277179,-1,6,GO:0042993,obsolete positive regulation of transcription factor import into nucleus,0.822337963
0,0.102472406,3,30,GO:0017148;GO:0034249,negative regulation of translation,0.82113164
0,0.10292622,2,46,GO:0051606,detection of stimulus,0.822004608
0,0.102947443,3,38,GO:0048608,reproductive structure development,0.820804598
0,0.103045445,2,106,GO:0008202,steroid metabolic process,0.819036697
0,0.103352139,2,6,GO:0006611,protein export from nucleus,0.819107551
0,0.104649843,2,22,GO:0007009,plasma membrane organization,0.823858447
0,0.104776428,5,33,GO:0008286,insulin receptor signaling pathway,0.822665148
0,0.10507056,4,10,GO:0007157;GO:0048563,post-embryonic animal organ morphogenesis,0.818325792
0,0.10507056,2,10,GO:0007519,skeletal muscle tissue development,0.818325792
0,0.10507056,2,10,GO:0008407,chaeta morphogenesis,0.818325792
0,0.105920005,2,24,GO:0090101;GO:0090288,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,0.819751693
0,0.10616867,7,8,GO:0033345;GO:0006530;GO:0006528;GO:0009068,asparagine metabolic process,0.819481982
0,0.107915116,3,133,GO:0009888,tissue development,0.825505618
0,0.10835787,2,13,GO:0006536,glutamate metabolic process,0.825224215
0,0.109021715,3,61,GO:0072593,reactive oxygen species metabolic process,0.826957494
0,0.109045112,3,12,GO:0031664,regulation of lipopolysaccharide-mediated signaling pathway,0.823273942
0,0.109045112,6,12,GO:0048662;GO:0048660,regulation of smooth muscle cell proliferation,0.823273942
0,0.109337508,2,25,GO:0061138;GO:0001763;GO:0048754,morphogenesis of a branching epithelium,0.821777778
0,0.109806749,2,98,GO:0055080;GO:0098771;GO:0050801,ion homeostasis,0.823170732
0,0.110169151,3,9,GO:0009409,response to cold,0.82289823
0,0.11095095,2,38,GO:0007005,mitochondrion organization,0.823898678
0,0.11095095,2,38,GO:0050808,synapse organization,0.823898678
0,0.111227309,2,201,GO:0007264,small GTPase mediated signal transduction,0.823406593
0,0.113229128,2,18,GO:0001539,cilium or flagellum-dependent cell motility,0.830921053
0,0.113971963,4,68,GO:0048812;GO:0120039;GO:0048858;GO:0032990,cell part morphogenesis,0.831838074
0,0.114483725,6,11,GO:0001754;GO:0046530,eye photoreceptor cell differentiation,0.821982759
0,0.114483725,2,11,GO:0007444,imaginal disc development,0.821982759
0,0.114483725,5,11,GO:0008045,motor neuron axon guidance,0.821982759
0,0.114483725,4,11,GO:0009948,anterior/posterior axis specification,0.821982759
0,0.114483725,5,11,GO:0042462;GO:0042461,photoreceptor cell development,0.821982759
0,0.114483725,4,11,GO:0048663,neuron fate commitment,0.821982759
0,0.114483725,2,11,GO:0051489,regulation of filopodium assembly,0.821982759
0,0.115052072,4,18,GO:1905952,regulation of lipid localization,0.823870968
0,0.115599638,7,14,GO:0009084,glutamine family amino acid biosynthetic process,0.824678112
0,0.116299021,3,8,GO:0007588,excretion,0.825695931
0,0.116486187,2,65,GO:0006869,lipid transport,0.824358974
0,0.117021557,2,13,GO:0048872,homeostasis of number of cells,0.825266525
0,0.117720222,5,183,GO:0034622,cellular protein-containing complex assembly,0.826170213
0,0.118464432,2,13,GO:0019233,sensory perception of pain,0.827494692
0,0.119149467,2,32,GO:0006959,humoral immune response,0.828495763
0,0.120220104,4,14,GO:0051099,positive regulation of binding,0.829915433
0,0.120324937,2,19,GO:0015850,organic hydroxy compound transport,0.828164557
0,0.120822096,3,7,GO:0045199;GO:0035090,maintenance of apical/basal cell polarity,0.829052632
0,0.122950912,3,7,GO:0021766,hippocampus development,0.836897275
0,0.122950912,2,7,GO:0040015,negative regulation of multicellular organism growth,0.836897275
0,0.123153052,2,32,GO:0007162,negative regulation of cell adhesion,0.836610879
0,0.123713219,3,12,GO:0007422,peripheral nervous system development,0.835416667
0,0.123713219,2,12,GO:0007616;GO:0007613,memory,0.835416667
0,0.12374886,2,7,GO:0009268,response to pH,0.832157676
0,0.12374886,2,7,GO:0030316,osteoclast differentiation,0.832157676
0,0.12402548,3,37,GO:0006766,vitamin metabolic process,0.831677019
0,0.124104255,2,37,GO:0030522,intracellular receptor signaling pathway,0.829958678
0,0.124934297,5,24,GO:0007051,spindle organization,0.832371134
0,0.125449107,2,30,GO:0072073,kidney epithelium development,0.832716049
0,0.126213841,1,16,GO:0043473,pigmentation,0.834702259
0,0.126955014,2,80,GO:0031347,regulation of defense response,0.836168033
0,0.127323746,3,9,GO:0006509;GO:0042987;GO:0042982,amyloid precursor protein metabolic process,0.834183673
0,0.127323746,2,9,GO:0050435,amyloid-beta metabolic process,0.834183673
0,0.127824805,6,81,GO:0051028;GO:0050658;GO:0050657;GO:0051236;GO:0015931,nucleic acid transport,0.833808554
0,0.128827327,2,133,GO:0048468,cell development,0.83546748
0,0.130279587,4,85,GO:0032101,regulation of response to external stimulus,0.840669371
0,0.130308734,3,394,GO:0006629,lipid metabolic process,0.839068826
0,0.130496154,3,183,GO:0001934;GO:0031401;GO:0042327;GO:0045937;GO:0010562,positive regulation of protein modification process,0.837777778
0,0.130655569,2,40,GO:0000041,transition metal ion transport,0.836491935
0,0.131461523,3,32,GO:0007281,germ cell development,0.83684739
0,0.131461523,5,32,GO:0060070,canonical Wnt signaling pathway,0.83684739
0,0.132510473,3,15,GO:0032663,regulation of interleukin-2 production,0.839378758
0,0.132762609,2,13,GO:0008356,asymmetric cell division,0.83742515
0,0.132762609,2,13,GO:0010453,regulation of cell fate commitment,0.83742515
0,0.132858251,4,17,GO:0046488,phosphatidylinositol metabolic process,0.83625498
0,0.133452572,5,104,GO:0046328;GO:0032872;GO:0070302;GO:0080135,regulation of cellular response to stress,0.837375746
0,0.133770726,2,8,GO:0034394,protein localization to cell surface,0.836904762
0,0.13408335,3,43,GO:0042391,regulation of membrane potential,0.836237624
0,0.134088984,4,45,GO:0045926,negative regulation of growth,0.83458498
0,0.134432758,3,364,GO:0009967;GO:0010647;GO:0023056;GO:0048584,positive regulation of response to stimulus,0.833629191
0,0.134731771,2,540,GO:0006508,proteolysis,0.832775591
0,0.136164615,3,460,GO:0033554;GO:0051716,cellular response to stimulus,0.837131631
0,0.137776891,3,48,GO:1902532,negative regulation of intracellular signal transduction,0.842843137
0,0.138027527,4,194,GO:0080134,regulation of response to stress,0.842563601
0,0.140028934,3,16,GO:0050728;GO:0031348,negative regulation of defense response,0.848925781
0,0.140868658,2,45,GO:0070838;GO:0072511,divalent inorganic cation transport,0.850097466
0,0.141344906,4,64,GO:0002009,morphogenesis of an epithelium,0.850291829
0,0.141635393,4,14,GO:0001751;GO:0045314;GO:0042478;GO:0110116;GO:0007474;GO:0045610;GO:0009608;GO:0042676;GO:0046667;GO:0046666;GO:0007451;GO:0035161;GO:0035165;GO:0035163;GO:0042688;GO:0042386;GO:0035153;GO:0035214;GO:0030708;GO:0048139;GO:0048138;GO:0007403;GO:0035172;GO:0007446;GO:0008587;GO:0035171;GO:0035168;GO:0042387;GO:0007478;GO:0007560;GO:0035111;GO:0035170;GO:0007521;GO:0045316;GO:0042480;GO:0110118;GO:0035157;GO:0009996;GO:0035155;GO:0007314;GO:0007309;GO:0030720;GO:0051674;GO:0030713;GO:0045750;GO:0048052;GO:0007464;GO:0001752;GO:0042706;GO:0046552;GO:0045466;GO:0045463;GO:0007460;GO:0042686;GO:0051890;GO:2000043;GO:1905207;GO:0042689;GO:0045468;GO:0016330;GO:0007419;GO:0007473;GO:0007449,retinal cell programmed cell death,0.84748062
0,0.141635393,2,14,GO:0046329;GO:0032873;GO:0070303,negative regulation of stress-activated MAPK cascade,0.84748062
0,0.141943184,2,17,GO:0043393,regulation of protein binding,0.846711799
0,0.142325767,2,463,GO:0007155;GO:0022610,cell adhesion,0.846138996
0,0.144855898,2,69,GO:0043123;GO:0043122,regulation of I-kappaB kinase/NF-kappaB signaling,0.852408478
0,0.145227878,2,13,GO:0051781;GO:0051302,regulation of cell division,0.851826923
0,0.14549369,4,37,GO:0009952,anterior/posterior pattern specification,0.851055662
0,0.146548853,2,171,GO:0007049,cell cycle,0.85335249
0,0.148440478,3,85,GO:0006979,response to oxidative stress,0.858795411
0,0.150228633,2,51,GO:0001933;GO:0031400;GO:0042326;GO:0045936;GO:0010563,negative regulation of protein modification process,0.86278626
0,0.150335003,2,15,GO:0007498,mesoderm development,0.861428571
0,0.151055872,2,126,GO:0009719,response to endogenous stimulus,0.861311787
0,0.151486921,3,43,GO:0051865,protein autoubiquitination,0.861100569
0,0.1526813,2,11,GO:0007220,Notch receptor processing,0.864299242
0,0.152967298,5,10,GO:0045739;GO:2001022,positive regulation of response to DNA damage stimulus,0.863327032
0,0.153547056,5,248,GO:0045892;GO:1903507;GO:2000113;GO:1902679;GO:0010558;GO:0031327;GO:0051253;GO:0009890;GO:0045934,negative regulation of biosynthetic process,0.864433962
0,0.153635779,2,39,GO:1901136,carbohydrate derivative catabolic process,0.863182674
0,0.154402226,3,310,GO:0065003;GO:0043933,protein-containing complex subunit organization,0.864003759
0,0.154628404,3,18,GO:0032720;GO:0032680;GO:1903556;GO:1903555,regulation of tumor necrosis factor superfamily cytokine production,0.861891386
0,0.154628404,7,18,GO:0050869;GO:0050864;GO:0051250;GO:0070664;GO:0002634,regulation of B cell activation,0.861891386
0,0.155593745,3,9,GO:0042773,ATP synthesis coupled electron transport,0.86364486
0,0.156083442,4,9,GO:0002763;GO:0002761,positive regulation of myeloid leukocyte differentiation,0.861918063
0,0.156083442,2,9,GO:0010043,response to zinc ion,0.861918063
0,0.156467067,3,17,GO:0033692;GO:0000271;GO:0034637,cellular carbohydrate biosynthetic process,0.861802974
0,0.158439839,2,18,GO:0006691;GO:0031408;GO:0031407,leukotriene metabolic process,0.866512059
0,0.158864803,3,16,GO:0007298;GO:0007297,border follicle cell migration,0.864787431
0,0.158864803,2,16,GO:0060562,epithelial tube morphogenesis,0.864787431
0,0.160496696,2,102,GO:0007267;GO:0023052,signaling,0.867712177
0,0.161715062,2,19,GO:0002695;GO:0050866,negative regulation of cell activation,0.86587156
0,0.161715062,4,19,GO:0043901,negative regulation of multi-organism process,0.86587156
0,0.161715062,2,19,GO:0050688,regulation of defense response to virus,0.86587156
0,0.162915418,4,11,GO:0030521,androgen receptor signaling pathway,0.868772894
0,0.16337798,3,72,GO:0035295;GO:0060429,tube development,0.869012797
0,0.163442307,4,14,GO:0097305,response to alcohol,0.867609489
0,0.164008489,2,283,GO:0001932;GO:0031399;GO:0042325;GO:0019220;GO:0051174,regulation of protein modification process,0.867941712
0,0.164990221,3,12,GO:0033619,membrane protein proteolysis,0.869363636
0,0.16528606,3,339,GO:1902531,regulation of intracellular signal transduction,0.868602541
0,0.165355072,5,10,GO:0071221;GO:0070339;GO:0071220;GO:0032493;GO:0071726;GO:0071724;GO:0042496;GO:0070340;GO:0042494,cellular response to bacterial lipopeptide,0.867119565
0,0.165569497,4,16,GO:0007185,transmembrane receptor protein tyrosine phosphatase signaling pathway,0.866184448
0,0.165771756,2,10,GO:0046320,regulation of fatty acid oxidation,0.865433213
0,0.166774011,2,65,GO:0015711;GO:0006820,anion transport,0.866666667
0,0.166941872,4,44,GO:0030031;GO:0120031,cell projection assembly,0.865647482
0,0.167228093,2,17,GO:0016331;GO:0007391,morphogenesis of embryonic epithelium,0.86481149
0,0.167674592,2,91,GO:0030163,protein catabolic process,0.864336918
0,0.168267812,3,178,GO:0006468;GO:0016310,phosphorylation,0.863953488
0,0.169551395,4,53,GO:0048638,regulation of developmental growth,0.865535714
0,0.169974027,3,43,GO:0008360,regulation of cell shape,0.865597148
0,0.170266908,2,39,GO:0007409,axonogenesis,0.864768683
0,0.17112206,2,1017,GO:0048522;GO:0048518,positive regulation of biological process,0.865630551
0,0.172744508,2,40,GO:0016482,cytosolic transport,0.868351064
0,0.174111927,2,109,GO:0051090,regulation of DNA-binding transcription factor activity,0.871504425
0,0.175404343,4,245,GO:0032270;GO:0051247,positive regulation of protein metabolic process,0.873233216
0,0.175428108,4,18,GO:0045747,positive regulation of Notch signaling pathway,0.871693122
0,0.17874443,6,11,GO:0007188;GO:0007187,G protein-coupled receptor signaling pathway,
0,0.180016929,3,80,GO:0043406;GO:0043405;GO:0071902,regulation of MAP kinase activity,0.878998243
0,0.180018859,2,322,GO:1901566,organonitrogen compound biosynthetic process,0.87745614
0,0.18010827,2,12,GO:0016574,histone ubiquitination,0.87591944
0,0.180169066,3,11,GO:0032490;GO:0098581;GO:0009595,detection of external biotic stimulus,0.874475524
0,0.18018503,5,16,GO:0006783;GO:0006779;GO:0033014,porphyrin-containing compound biosynthetic process,0.872949389
0,0.180261312,7,53,GO:0009064,glutamine family amino acid metabolic process,0.871689895
0,0.181960455,5,21,GO:0055072,iron ion homeostasis,0.873652174
0,0.183468021,5,19,GO:0014706,striated muscle tissue development,0.875607639
0,0.1840706,2,497,GO:0006928,movement of cell or subcellular component,0.875389948
0,0.185149623,2,67,GO:0044262,cellular carbohydrate metabolic process,0.876643599
0,0.185578668,3,205,GO:0002682,regulation of immune system process,0.876252159
0,0.186269259,2,21,GO:0046165,alcohol biosynthetic process,0.876293103
0,0.187113168,2,26,GO:0007626,locomotory behavior,0.877280551
0,0.187168722,5,11,GO:0002573,myeloid leukocyte differentiation,0.875945017
0,0.187687122,2,188,GO:0043603,cellular amide metabolic process,0.875986278
0,0.189043902,2,59,GO:0002694;GO:0050865,regulation of cell activation,0.87739726
0,0.190728942,3,46,GO:0043433,negative regulation of DNA-binding transcription factor activity,0.879316239
0,0.191350945,3,20,GO:0001709,cell fate determination,0.879180887
0,0.192583211,2,46,GO:0002224;GO:0002221;GO:0002758;GO:0002218,activation of innate immune response,0.880579216
0,0.193131765,4,59,GO:0030855,epithelial cell differentiation,0.879931973
0,0.195125728,6,24,GO:0002822;GO:0002819,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.883022071
0,0.196607064,3,212,GO:0006952,defense response,0.886101695
0,0.199079931,3,21,GO:0009886,post-embryonic animal morphogenesis,0.891539763
0,0.199339352,2,570,GO:0007166,cell surface receptor signaling pathway,0.890456081
0,0.199820543,2,424,GO:0006396,RNA processing,0.889966273
0,0.201508259,5,163,GO:0045859;GO:0043549;GO:0051338,regulation of transferase activity,0.890824916
0,0.202257963,7,12,GO:0051453;GO:0030641;GO:0030004,regulation of intracellular pH,0.89092437
0,0.202564055,2,129,GO:0008284,positive regulation of cell population proliferation,0.890184564
0,0.203094498,3,263,GO:0042592,homeostatic process,0.889530988
0,0.203140398,3,96,GO:0022900,electron transport chain,0.88812709
0,0.204311924,3,88,GO:0048729,tissue morphogenesis,0.889816361
0,0.20665797,2,22,GO:0000904,cell morphogenesis involved in differentiation,0.890199336
0,0.20665797,3,22,GO:0001708,cell fate specification,0.890199336
0,0.20665797,4,22,GO:0043409,negative regulation of MAPK cascade,0.890199336
0,0.206678577,2,85,GO:0007219,Notch signaling pathway,0.88880597
0,0.208503496,3,104,GO:0030001,metal ion transport,0.890562914
0,0.210581366,2,16,GO:0035162,embryonic hemopoiesis,0.894628099
0,0.211014784,2,101,GO:0051188,cofactor biosynthetic process,0.894224422
0,0.213646284,2,27,GO:0061041;GO:1903034,regulation of response to wounding,0.89785832
0,0.214004087,2,150,GO:0007154,cell communication,0.897121711
0,0.215653172,2,13,GO:0021987,cerebral cortex development,0.897786885
0,0.215653172,2,13,GO:0060271;GO:0044782,cilium assembly,0.897786885
0,0.217715627,2,259,GO:0042127,regulation of cell population proliferation,0.900900164
0,0.218517393,3,116,GO:0090066;GO:0032535,regulation of anatomical structure size,0.900653595
0,0.219580138,4,28,GO:0002831,regulation of response to biotic stimulus,0.899918567
0,0.219580138,2,28,GO:0032088,negative regulation of NF-kappaB transcription factor activity,0.899918567
0,0.219807493,2,75,GO:0006644,phospholipid metabolic process,0.898861789
0,0.222466011,2,153,GO:0055085,transmembrane transport,0.902516234
0,0.223010364,2,369,GO:0065009,regulation of molecular function,0.902269044
0,0.223355092,4,44,GO:0016197,endosomal transport,0.901456311
0,0.225398031,2,29,GO:0032480;GO:0032479,regulation of type I interferon production,0.9025
0,0.225398031,2,29,GO:0042129;GO:0050670;GO:0032944;GO:0070663,regulation of leukocyte proliferation,0.9025
0,0.225797172,4,21,GO:0042168;GO:0006778,porphyrin-containing compound metabolic process,0.901771337
0,0.228784665,4,51,GO:0007015,actin filament organization,0.906189711
0,0.229079227,2,585,GO:0031325;GO:0009893;GO:0010604;GO:0051173,positive regulation of metabolic process,0.905377207
0,0.230065694,2,14,GO:0045444,fat cell differentiation,0.9044
0,0.230065694,2,14,GO:0048854,brain morphogenesis,0.9044
0,0.231283812,2,16,GO:0006282;GO:2001020,regulation of response to DNA damage stimulus,0.905910543
0,0.232536659,2,18,GO:0043967,histone H4 acetylation,0.907256778
0,0.234303171,4,173,GO:1902533,positive regulation of intracellular signal transduction,0.909156051
0,0.235518516,2,26,GO:0010631,epithelial cell migration,0.908968254
0,0.235518516,2,26,GO:0060537,muscle tissue development,0.908968254
0,0.236590109,7,15,GO:0007250;GO:1901224;GO:1901222,positive regulation of NIK/NF-kappaB signaling,0.908954041
0,0.236920645,3,66,GO:0001525,angiogenesis,0.907990506
0,0.238268847,3,70,GO:0007601;GO:0050953,sensory perception of light stimulus,0.909083728
0,0.238388869,2,33,GO:0051098,regulation of binding,0.907807571
0,0.239642341,2,30,GO:0055076,transition metal ion homeostasis,0.908661417
0,0.242219832,3,239,GO:0006886,intracellular protein transport,0.911556604
0,0.245781751,2,15,GO:0043627,response to estrogen,0.913871473
0,0.245781751,3,15,GO:1902107,positive regulation of leukocyte differentiation,0.913871473
0,0.245975118,3,38,GO:0006650,glycerophospholipid metabolic process,0.912989045
0,0.246938756,3,52,GO:0043062;GO:0030198,extracellular structure organization,0.91375
0,0.250013904,3,16,GO:0002460;GO:0002250;GO:0042088;GO:0045410;GO:0045408,adaptive immune response,0.918486739
0,0.250643923,3,16,GO:0019217,regulation of fatty acid metabolic process,0.917757009
0,0.251253742,3,31,GO:1901617,organic hydroxy compound biosynthetic process,0.917340591
0,0.251765724,3,303,GO:0032879,regulation of localization,0.916770186
0,0.253470511,6,59,GO:0006366,transcription by RNA polymerase II,0.91875969
0,0.25354675,2,194,GO:0051301,cell division,0.917414861
0,0.254364045,2,64,GO:0000956;GO:0006402;GO:0006401,RNA catabolic process,0.917851623
0,0.254417287,3,57,GO:0000910,cytokinesis,0.916435185
0,0.255456603,3,24,GO:0032870,cellular response to hormone stimulus,0.916486903
0,0.255717248,3,29,GO:0045165,cell fate commitment,0.915461538
0,0.257288572,3,190,GO:0007167;GO:0007169,enzyme linked receptor protein signaling pathway,0.916973886
0,0.259057424,2,34,GO:1901568;GO:0006690,fatty acid derivative metabolic process,0.917407975
0,0.260415864,4,141,GO:0048878,chemical homeostasis,0.917917305
0,0.261050888,3,107,GO:0061024,membrane organization,0.917584098
0,0.261790309,3,112,GO:0043043;GO:0043604,amide biosynthetic process,0.917175573
0,0.26218873,4,30,GO:0000902,cell morphogenesis,0.916463415
0,0.263698896,5,25,GO:0071396,cellular response to lipid,0.917579909
0,0.26379584,1,123,GO:0008283,cell population proliferation,0.91656535
0,0.263969043,6,58,GO:0046330;GO:0032874;GO:0070304,positive regulation of stress-activated MAPK cascade,0.915629742
0,0.266934015,3,17,GO:0030011,maintenance of cell polarity,0.919015152
0,0.267305268,3,154,GO:0034655;GO:0019439;GO:0044270;GO:0046700;GO:1901361,organic cyclic compound catabolic process,0.918078669
0,0.268300899,2,76,GO:0070925,organelle assembly,0.917749245
0,0.268673485,2,21,GO:0008333,endosome to lysosome transport,0.916968326
0,0.27163724,2,17,GO:0030534,adult behavior,0.919728916
0,0.272069707,5,70,GO:0072330,monocarboxylic acid biosynthetic process,0.91887218
0,0.273024085,4,231,GO:0006811,ion transport,0.919369369
0,0.273400157,2,17,GO:0042475,odontogenesis of dentin-containing tooth,0.918290855
0,0.274521181,2,203,GO:0009968;GO:0010648;GO:0023057;GO:0048585,negative regulation of response to stimulus,0.918263473
0,0.274754686,4,32,GO:0009953,dorsal/ventral pattern formation,0.917339312
0,0.277674442,3,39,GO:0001818,negative regulation of cytokine production,0.919477612
0,0.279613476,3,277,GO:0050877;GO:0003008,system process,0.921609538
0,0.281787162,3,218,GO:1901135,carbohydrate derivative metabolic process,0.922693452
0,0.282356447,5,40,GO:0032102,negative regulation of response to external stimulus,0.921991085
0,0.283000256,4,59,GO:0010038,response to metal ion,0.921290801
0,0.285882545,2,103,GO:0071900,regulation of protein serine/threonine kinase activity,0.923925926
0,0.28680631,4,18,GO:0006885;GO:0055067,regulation of pH,0.924186391
0,0.288733284,2,19,GO:0032755,positive regulation of interleukin-6 production,0.925184638
0,0.290789437,3,65,GO:0043161;GO:0010498,proteasome-mediated ubiquitin-dependent protein catabolic process,0.926622419
0,0.290798669,5,70,GO:0006875;GO:0055065,metal ion homeostasis,0.92533137
0,0.292697305,3,35,GO:0008593,regulation of Notch signaling pathway,0.927352941
0,0.292829881,2,250,GO:0050790,regulation of catalytic activity,0.926284875
0,0.292856629,2,19,GO:0045197;GO:0035088;GO:0061245,establishment or maintenance of bipolar cell polarity,0.924926686
0,0.293498855,3,21,GO:0030433;GO:0036503,ubiquitin-dependent ERAD pathway,0.924450952
0,0.293938976,2,141,GO:0045944,positive regulation of transcription by RNA polymerase II,0.923538012
0,0.295088792,3,29,GO:0071229,cellular response to acid chemical,0.923722628
0,0.29696157,2,63,GO:0045088;GO:0045089;GO:0031349,regulation of innate immune response,0.924489796
0,0.29724022,5,69,GO:0006913;GO:0051169,nucleocytoplasmic transport,0.923508006
0,0.29863134,2,42,GO:0006633,fatty acid biosynthetic process,0.924127907
0,0.298757884,2,20,GO:0043113;GO:0051668,localization within membrane,0.922931785
0,0.300403543,5,131,GO:0008285,negative regulation of cell population proliferation,0.924202899
0,0.301591137,4,84,GO:0043254;GO:0008064;GO:0030832;GO:0030833;GO:0032271,regulation of protein complex assembly,0.925180897
0,0.304332261,5,86,GO:1902903;GO:0110053;GO:0032956;GO:0032970,regulation of actin cytoskeleton organization,0.928034682
0,0.308060028,2,1036,GO:0048856,anatomical structure development,0.931890332
0,0.308586199,2,46,GO:0002683,negative regulation of immune system process,0.931051873
0,0.310825216,2,21,GO:0031532,actin cytoskeleton reorganization,0.932302158
0,0.312663304,3,47,GO:0045765;GO:1901342,regulation of vasculature development,0.933764368
0,0.313302568,3,21,GO:0071219;GO:0071216,cellular response to biotic stimulus,0.933070301
0,0.314057989,2,43,GO:0016051,carbohydrate biosynthetic process,0.932449857
0,0.317552927,4,144,GO:0007600,sensory perception,0.935479256
0,0.317787203,3,58,GO:0046486,glycerolipid metabolic process,0.9345
0,0.318650274,2,44,GO:0008654,phospholipid biosynthetic process,0.933880171
0,0.319886478,3,125,GO:0006518,peptide metabolic process,0.933831909
0,0.320036378,2,98,GO:0006732,coenzyme metabolic process,0.932716927
0,0.320599635,3,109,GO:0000209,protein polyubiquitination,0.931818182
0,0.320754633,2,100,GO:0051493,regulation of cytoskeleton organization,0.930638298
0,0.322097244,2,243,GO:0044255,cellular lipid metabolic process,0.930311615
0,0.325228528,3,22,GO:0002755;GO:0034130;GO:0034134,MyD88-dependent toll-like receptor signaling pathway,0.93281471
0,0.328189,6,51,GO:0050863;GO:0051249;GO:1903037;GO:0022407,regulation of lymphocyte activation,0.935946328
0,0.330651252,2,42,GO:2000027,regulation of animal organ morphogenesis,0.937729196
0,0.330996593,2,34,GO:0009266,response to temperature stimulus,0.937253521
0,0.335195913,2,233,GO:0005975,carbohydrate metabolic process,0.941420534
0,0.335503258,3,53,GO:0043900,regulation of multi-organism process,0.940589888
0,0.335657334,2,43,GO:0050890;GO:0007611,cognition,0.939340813
0,0.337101357,2,154,GO:0006812,cation transport,0.939285714
0,0.337305445,2,154,GO:0044419,interspecies interaction between organisms,0.938321678
0,0.338962982,2,29,GO:0030097,hemopoiesis,0.938826816
0,0.339640011,2,53,GO:0050804;GO:0099177,modulation of chemical synaptic transmission,0.938075314
0,0.340985895,3,89,GO:0051640,organelle localization,0.93816156
0,0.346662734,2,68,GO:0016570;GO:0016569,covalent chromatin modification,0.943393602
0,0.348306883,3,146,GO:0040008,regulation of growth,0.943472222
0,0.349264088,2,24,GO:0010565,regulation of cellular ketone metabolic process,0.942995839
0,0.350011122,2,23,GO:0042476,odontogenesis,0.941009682
0,0.350011122,3,23,GO:1902105,regulation of leukocyte differentiation,0.941009682
0,0.350215887,3,72,GO:0002757;GO:0002764,immune response-activating signal transduction,0.939986188
0,0.358939772,2,60,GO:0002697,regulation of immune effector process,0.947034483
0,0.35958744,2,24,GO:0045494,photoreceptor cell maintenance,0.945936639
0,0.370647889,2,26,GO:0008063;GO:0034142,toll-like receptor 4 signaling pathway,0.951646091
0,0.370647889,2,26,GO:0009593,detection of chemical stimulus,0.951646091
0,0.370647889,3,26,GO:0042108;GO:0042035,regulation of cytokine biosynthetic process,0.951646091
0,0.371189508,2,25,GO:0040014,regulation of multicellular organism growth,0.950547945
0,0.37310619,2,30,GO:0030518;GO:0043401;GO:0009755,hormone-mediated signaling pathway,0.950957592
0,0.373598516,4,25,GO:0030099,myeloid cell differentiation,0.950273224
0,0.374220679,3,113,GO:0009887,animal organ morphogenesis,0.949931787
0,0.374561178,2,33,GO:0016485,protein processing,0.948910082
0,0.374693586,2,86,GO:0043066;GO:0043069;GO:0060548,negative regulation of cell death,0.947687075
0,0.37652515,4,52,GO:0001667,ameboidal-type cell migration,0.947690217
0,0.381708269,2,30,GO:0051054,positive regulation of DNA metabolic process,0.950610583
0,0.383931854,2,259,GO:0007010,cytoskeleton organization,0.952235772
0,0.385047741,3,26,GO:0045639;GO:0045637;GO:1903708,positive regulation of hemopoiesis,0.951691475
0,0.387809729,3,77,GO:0097435,supramolecular fiber organization,0.952364865
0,0.387816125,2,97,GO:0006278;GO:0071897,DNA biosynthetic process,0.951079622
0,0.38798146,4,35,GO:0048568,embryonic organ development,0.950202156
0,0.393510363,2,217,GO:0043085;GO:0044093,positive regulation of molecular function,0.95269179
0,0.406241568,2,82,GO:0001817,regulation of cytokine production,0.960954301
0,0.414913024,4,90,GO:0120036,plasma membrane bounded cell projection organization,0.965033557
0,0.416017273,3,81,GO:0010035,response to inorganic substance,0.964544236
0,0.417839227,5,38,GO:0007041;GO:0007034,vacuolar transport,0.964658635
0,0.420486414,5,85,GO:0051259,protein complex oligomerization,0.965708556
0,0.424729871,3,50,GO:0001101,response to acid chemical,0.966622163
0,0.435689084,2,169,GO:0006955,immune response,0.973
0,0.442143608,3,79,GO:0030003;GO:0006873;GO:0055082,cellular chemical homeostasis,0.976364847
0,0.444066007,2,94,GO:0000226,microtubule cytoskeleton organization,0.975731383
0,0.444328799,2,153,GO:0008610,lipid biosynthetic process,0.974833997
0,0.447649637,2,43,GO:0006874;GO:0055074;GO:0072503;GO:0072507,divalent inorganic cation homeostasis,0.975928382
0,0.447836611,3,34,GO:0045185,maintenance of protein location,0.974900662
0,0.448883088,2,91,GO:0044092,negative regulation of molecular function,0.974206349
0,0.450523093,5,74,GO:0007156;GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,0.973976222
0,0.45904634,4,436,GO:0006796;GO:0006793,phosphorus metabolic process,0.978759894
0,0.464064827,2,46,GO:0048534,hematopoietic or lymphoid organ development,0.980961792
0,0.466836972,5,108,GO:0006631,fatty acid metabolic process,0.981118421
0,0.467882133,2,147,GO:0030036;GO:0030029,actin filament-based process,0.980091984
0,0.470377661,2,82,GO:0000122,negative regulation of transcription by RNA polymerase II,0.97992126
0,0.47307382,3,47,GO:0051604,protein maturation,0.980406291
0,0.474704376,2,340,GO:0009653,anatomical structure morphogenesis,0.980562827
0,0.478135727,2,632,GO:0048869,cellular developmental process,0.981568627
0,0.481823357,2,63,GO:0071495,cellular response to endogenous stimulus,0.982637076
0,0.483332483,2,88,GO:0098609,cell-cell adhesion,0.982333768
0,0.486621699,3,252,GO:0019637,organophosphate metabolic process,0.983007813
0,0.487927201,4,36,GO:0002521,leukocyte differentiation,0.98289987
0,0.500156016,2,68,GO:1901701,cellular response to oxygen-containing compound,0.987467532
0,0.515511967,3,107,GO:0048598,embryonic morphogenesis,0.994228275
0,0.516560927,2,285,GO:0006357,regulation of transcription by RNA polymerase II,0.993264249
0,0.522690707,3,78,GO:0015672,monovalent inorganic cation transport,0.994825356
0,0.523682276,5,106,GO:0002253;GO:0050778,positive regulation of immune response,0.993927649
0,0.525960848,2,76,GO:0006260,DNA replication,0.993290323
0,0.527205804,2,165,GO:0090407,organophosphate biosynthetic process,0.992783505
0,0.530242897,3,201,GO:0006091;GO:0055114,generation of precursor metabolites and energy,0.993629344
0,0.537316383,4,44,GO:0062012,regulation of small molecule metabolic process,0.994987147
0,0.538764132,2,47,GO:0008037;GO:0008038,cell recognition,0.994159178
0,0.540130259,4,81,GO:0033993,response to lipid,0.993653846
0,0.540453766,2,345,GO:0006397;GO:0016071,mRNA metabolic process,0.992637644
0,0.540540991,2,210,GO:0008380,RNA splicing,0.991368286
0,0.541188769,3,439,GO:0030154,cell differentiation,0.990485313
0,0.542727815,2,149,GO:0002684,positive regulation of immune system process,0.990369898
0,0.546606973,2,46,GO:0051235,maintenance of location,0.991401274
0,0.547981534,3,84,GO:0009725,response to hormone,0.990839695
0,0.550963562,4,46,GO:0043507;GO:0043506,regulation of JUN kinase activity,0.99047014
0,0.559649744,5,47,GO:0019216,regulation of lipid metabolic process,0.993274112
0,0.567813363,2,53,GO:0001701;GO:0043009,chordate embryonic development,0.995183777
0,0.575197264,2,168,GO:0032787,monocarboxylic acid metabolic process,0.997088608
0,0.575542476,2,205,GO:0048731,system development,0.996017699
0,0.579028971,2,98,GO:0071310,cellular response to organic substance,0.996022727
0,0.579931022,4,47,GO:1903706,regulation of hemopoiesis,0.994955864
0,0.585963277,2,51,GO:0002237,response to molecule of bacterial origin,0.996599496
0,0.589123756,1,306,GO:0002376,immune system process,0.995974843
0,0.591387886,3,123,GO:0045087,innate immune response,0.995477387
0,0.594161426,3,157,GO:0007018,microtubule-based movement,0.995420326
0,0.601688363,2,384,GO:0045893;GO:0010628;GO:1903508;GO:1902680;GO:0010557;GO:0031328;GO:0051254;GO:0009891;GO:0045935,positive regulation of biosynthetic process,0.996679198
0,0.603911954,2,245,GO:0007017,microtubule-based process,0.995932416
0,0.611575125,5,55,GO:0001819,positive regulation of cytokine production,0.997875
0,0.627538511,2,133,GO:0070887,cellular response to chemical stimulus,1
0,0.62865842,2,134,GO:0050776,regulation of immune response,1
0,0.652627306,3,170,GO:1901700,response to oxygen-containing compound,1
0,0.663472178,2,88,GO:0006364;GO:0016072,rRNA metabolic process,1
0,0.681340173,3,141,GO:0007411;GO:0097485,axon guidance,1
0,0.687498938,3,277,GO:0010033,response to organic substance,1
0,0.694720473,4,80,GO:0009792,embryo development ending in birth or egg hatching,1
0,0.705978825,7,1110,GO:0006355;GO:1903506;GO:2001141;GO:0051252,regulation of RNA metabolic process,1
0,0.717061566,3,722,GO:0006351;GO:0097659;GO:0032774,RNA biosynthetic process,1
0,0.723526273,3,153,GO:0006325,chromatin organization,1
0,0.732342904,2,388,GO:0042221,response to chemical,1
0,0.743826757,2,83,GO:0006954,inflammatory response,1
0,0.744571702,4,100,GO:0010243;GO:1901698,response to nitrogen compound,1
0,0.767412024,2,144,GO:0006457,protein folding,1
0,0.783249269,2,1224,GO:0034654;GO:0018130;GO:0044271;GO:1901362;GO:0019438;GO:0034645;GO:0009059,cellular nitrogen compound biosynthetic process,1
0,0.789901606,2,159,GO:0019725,cellular homeostasis,1
0,0.853654865,2,112,GO:0045597,positive regulation of cell differentiation,1
0,0.919740766,2,163,GO:0051094,positive regulation of developmental process,1
0,0.925018015,2,225,GO:0051240,positive regulation of multicellular organismal process,1
0,1,1,14,GO:0000003,reproduction,1
0,1,4,4,GO:0000022;GO:0051231,mitotic spindle elongation,1
0,1,2,4,GO:0000028,ribosomal small subunit assembly,1
0,1,4,6,GO:0000050;GO:0019627;GO:0071941,urea metabolic process,1
0,1,-1,5,GO:0000059,obsolete protein import into nucleus,
0,1,-1,4,GO:0000060,obsolete protein import into nucleus,
0,1,5,6,GO:0000070,mitotic sister chromatid segregation,1
0,1,7,4,GO:0000076,DNA replication checkpoint,1
0,1,3,22,GO:0000079;GO:1904029,regulation of cyclin-dependent protein serine/threonine kinase activity,1
0,1,4,20,GO:0000082;GO:0044843,cell cycle G1/S phase transition,1
0,1,4,10,GO:0000089;GO:0051323,metaphase,1
0,1,4,4,GO:0000103,sulfate assimilation,1
0,1,5,4,GO:0000132;GO:0051294,establishment of spindle orientation,1
0,1,3,44,GO:0000165;GO:0023014,MAPK cascade,1
0,1,5,33,GO:0000184,nuclear-transcribed mRNA catabolic process,
0,1,2,30,GO:0000187,activation of MAPK activity,1
0,1,2,4,GO:0000188,inactivation of MAPK activity,1
0,1,2,15,GO:0000216;GO:0000084;GO:0051320,S phase,1
0,1,4,23,GO:0000236;GO:0098763,mitotic cell cycle phase,1
0,1,2,12,GO:0000272,polysaccharide catabolic process,1
0,1,4,27,GO:0000302,response to reactive oxygen species,1
0,1,2,4,GO:0000354,cis assembly of pre-catalytic spliceosome,1
0,1,2,5,GO:0000387,spliceosomal snRNP assembly,1
0,1,2,6,GO:0000389,mRNA 3'-splice site recognition,1
0,1,3,5,GO:0000460,maturation of 5.8S rRNA,1
0,1,3,4,GO:0000722,telomere maintenance via recombination,1
0,1,4,8,GO:0000731,DNA synthesis involved in DNA repair,1
0,1,3,11,GO:0000819,sister chromatid segregation,1
0,1,4,33,GO:0001501,skeletal system development,1
0,1,2,10,GO:0001502,cartilage condensation,1
0,1,2,40,GO:0001503,ossification,1
0,1,4,15,GO:0001508,action potential,1
0,1,2,6,GO:0001510,RNA methylation,1
0,1,7,8,GO:0001516;GO:0006693;GO:0046457;GO:0006636,prostaglandin metabolic process,1
0,1,3,8,GO:0001522,pseudouridine synthesis,1
0,1,5,8,GO:0001523;GO:0016101;GO:0006721,terpenoid metabolic process,1
0,1,2,6,GO:0001541,ovarian follicle development,1
0,1,3,5,GO:0001542;GO:0030728;GO:0042376;GO:0009111;GO:0042374;GO:1901662;GO:0042182;GO:0034698;GO:0033574,ovulation,1
0,1,2,6,GO:0001550,ovarian cumulus expansion,1
0,1,2,5,GO:0001553,luteinization,1
0,1,2,15,GO:0001568,blood vessel development,1
0,1,2,20,GO:0001570,vasculogenesis,1
0,1,2,5,GO:0001649,osteoblast differentiation,1
0,1,2,52,GO:0001654;GO:0007423,sensory organ development,1
0,1,2,18,GO:0001656,metanephros development,1
0,1,3,39,GO:0001666;GO:0036293;GO:0070482,response to oxygen levels,1
0,1,2,4,GO:0001676,long-chain fatty acid metabolic process,1
0,1,2,6,GO:0001678,cellular glucose homeostasis,1
0,1,2,4,GO:0001702,gastrulation with mouth forming second,1
0,1,3,9,GO:0001736;GO:0007164,establishment of tissue polarity,1
0,1,2,13,GO:0001755,neural crest cell migration,1
0,1,2,4,GO:0001759,organ induction,1
0,1,4,4,GO:0001836,release of cytochrome c from mitochondria,1
0,1,6,7,GO:0001841,neural tube formation,1
0,1,5,18,GO:0001843;GO:0060606,neural tube closure,1
0,1,2,7,GO:0001885,endothelial cell development,1
0,1,2,10,GO:0001889,liver development,1
0,1,2,27,GO:0001894,tissue homeostasis,1
0,1,3,4,GO:0001895,retina homeostasis,1
0,1,2,15,GO:0001938;GO:0001936,regulation of endothelial cell proliferation,1
0,1,2,6,GO:0001942,hair follicle development,1
0,1,4,11,GO:0001944,vasculature development,1
0,1,2,5,GO:0001958;GO:0036075,endochondral ossification,1
0,1,4,9,GO:0001959;GO:0060759,regulation of response to cytokine stimulus,1
0,1,3,5,GO:0001967,suckling behavior,1
0,1,3,6,GO:0001974,blood vessel remodeling,1
0,1,2,13,GO:0002011,morphogenesis of an epithelial sheet,1
0,1,2,10,GO:0002028,regulation of sodium ion transport,1
0,1,3,17,GO:0002053;GO:0010464,regulation of mesenchymal cell proliferation,1
0,1,2,9,GO:0002062,chondrocyte differentiation,1
0,1,3,5,GO:0002063;GO:0032933;GO:0071501;GO:0006991,chondrocyte development,1
0,1,4,16,GO:0002064,epithelial cell development,1
0,1,2,7,GO:0002066,columnar/cuboidal epithelial cell development,1
0,1,2,4,GO:0002088,lens development in camera-type eye,1
0,1,3,20,GO:0002119;GO:0002164,larval development,1
0,1,2,42,GO:0002252,immune effector process,1
0,1,3,11,GO:0002274,myeloid leukocyte activation,1
0,1,3,4,GO:0002312,B cell activation involved in immune response,1
0,1,2,5,GO:0002335,mature B cell differentiation,1
0,1,3,6,GO:0002366;GO:0002263;GO:0002285,leukocyte activation involved in immune response,1
0,1,2,6,GO:0002443,leukocyte mediated immunity,1
0,1,2,18,GO:0002474,antigen processing and presentation of peptide antigen via MHC class I,1
0,1,2,6,GO:0002551;GO:0097531;GO:0016601,Rac protein signal transduction,1
0,1,2,12,GO:0002637;GO:0051023,regulation of immunoglobulin production,1
0,1,2,4,GO:0002639,positive regulation of immunoglobulin production,1
0,1,2,9,GO:0002685,regulation of leukocyte migration,1
0,1,3,4,GO:0002687,positive regulation of leukocyte migration,1
0,1,2,13,GO:0002698,negative regulation of immune effector process,1
0,1,2,20,GO:0002699,positive regulation of immune effector process,1
0,1,2,21,GO:0002700,regulation of production of molecular mediator of immune response,1
0,1,6,13,GO:0002702,positive regulation of production of molecular mediator of immune response,1
0,1,2,14,GO:0002703,regulation of leukocyte mediated immunity,1
0,1,3,12,GO:0002708;GO:0002705;GO:0002706,regulation of lymphocyte mediated immunity,1
0,1,3,10,GO:0002709;GO:0002824;GO:0002821,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,1
0,1,5,7,GO:0002720;GO:0002718,regulation of cytokine production involved in immune response,1
0,1,3,5,GO:0002726;GO:0002711;GO:0002724,positive regulation of T cell cytokine production,1
0,1,2,16,GO:0002756;GO:0034138,toll-like receptor 3 signaling pathway,1
0,1,2,7,GO:0002833,positive regulation of response to biotic stimulus,1
0,1,2,6,GO:0002862;GO:0002861,negative regulation of inflammatory response to antigenic stimulus,1
0,1,4,6,GO:0002865;GO:0002674;GO:0002864;GO:0002673;GO:0046325;GO:0010829;GO:0034763;GO:0045719;GO:0070874;GO:0080164;GO:0051775,regulation of nitric oxide metabolic process,1
0,1,3,6,GO:0002920,regulation of humoral immune response,1
0,1,2,8,GO:0003007,heart morphogenesis,1
0,1,5,6,GO:0003084;GO:0045777,positive regulation of blood pressure,1
0,1,5,5,GO:0003143;GO:0001947,heart looping,1
0,1,4,5,GO:0003148,outflow tract septum morphogenesis,1
0,1,3,14,GO:0003156,regulation of animal organ formation,1
0,1,4,12,GO:0003264;GO:2000136;GO:2000826,regulation of heart morphogenesis,1
0,1,2,5,GO:0003407,neural retina development,1
0,1,4,10,GO:0005513,detection of calcium ion,1
0,1,2,40,GO:0005976;GO:0044264,polysaccharide metabolic process,1
0,1,3,31,GO:0005977;GO:0006073;GO:0044042,cellular glucan metabolic process,1
0,1,2,10,GO:0005978;GO:0009250,glucan biosynthetic process,1
0,1,5,7,GO:0005979;GO:0010962;GO:0070873;GO:0032885;GO:0032881,regulation of polysaccharide metabolic process,1
0,1,5,9,GO:0005980;GO:0009251;GO:0044247;GO:0044275,cellular carbohydrate catabolic process,1
0,1,2,6,GO:0006002,fructose 6-phosphate metabolic process,1
0,1,5,18,GO:0006004,fucose metabolic process,1
0,1,3,40,GO:0006006,glucose metabolic process,1
0,1,2,5,GO:0006012,galactose metabolic process,1
0,1,2,10,GO:0006013,mannose metabolic process,1
0,1,2,24,GO:0006022,aminoglycan metabolic process,1
0,1,2,7,GO:0006024;GO:0006023,glycosaminoglycan biosynthetic process,1
0,1,2,6,GO:0006026,aminoglycan catabolic process,1
0,1,2,5,GO:0006029,proteoglycan metabolic process,1
0,1,3,10,GO:0006030;GO:1901071,glucosamine-containing compound metabolic process,1
0,1,5,4,GO:0006032;GO:1901072;GO:0046348,amino sugar catabolic process,1
0,1,2,14,GO:0006040,amino sugar metabolic process,1
0,1,3,4,GO:0006048;GO:0006047;GO:0009226;GO:0046349;GO:0009225,nucleotide-sugar biosynthetic process,1
0,1,4,8,GO:0006071;GO:0019400,alditol metabolic process,1
0,1,5,4,GO:0006072;GO:0052646,glycerol-3-phosphate metabolic process,1
0,1,2,24,GO:0006081,cellular aldehyde metabolic process,1
0,1,2,22,GO:0006094;GO:0019319;GO:0046364,monosaccharide biosynthetic process,1
0,1,6,45,GO:0006096;GO:0006757;GO:0009166;GO:0019359;GO:0042866;GO:0006165;GO:0046031;GO:1901292;GO:0019363;GO:0006090;GO:0009132;GO:0046939;GO:0009179;GO:0009135;GO:0009185,nucleoside phosphate catabolic process,1
0,1,2,10,GO:0006097;GO:0046487,glyoxylate metabolic process,1
0,1,2,6,GO:0006102,isocitrate metabolic process,1
0,1,5,12,GO:0006103,2-oxoglutarate metabolic process,1
0,1,7,4,GO:0006107,oxaloacetate metabolic process,1
0,1,7,5,GO:0006108,malate metabolic process,1
0,1,2,20,GO:0006109;GO:0043467,regulation of carbohydrate metabolic process,1
0,1,4,8,GO:0006111;GO:0010677;GO:0045912,regulation of gluconeogenesis,1
0,1,2,50,GO:0006112;GO:0015980,energy derivation by oxidation of organic compounds,1
0,1,3,11,GO:0006140;GO:1900542,regulation of nucleotide metabolic process,1
0,1,2,14,GO:0006144,purine nucleobase metabolic process,1
0,1,7,9,GO:0006189;GO:0006188;GO:0009168;GO:0046040;GO:0009127;GO:0009167;GO:0009126,purine ribonucleoside monophosphate metabolic process,1
0,1,-1,6,GO:0006200,obsolete ATP catabolic process,1
0,1,4,12,GO:0006206,pyrimidine nucleobase metabolic process,1
0,1,3,7,GO:0006207;GO:0019856,'de novo' pyrimidine nucleobase biosynthetic process,1
0,1,2,6,GO:0006208;GO:0046113,nucleobase catabolic process,1
0,1,4,14,GO:0006261,DNA-dependent DNA replication,1
0,1,2,9,GO:0006265,DNA topological change,1
0,1,2,7,GO:0006270,DNA replication initiation,1
0,1,3,6,GO:0006271;GO:0022616,DNA strand elongation,1
0,1,3,38,GO:0006275,regulation of DNA replication,1
0,1,2,8,GO:0006283,transcription-coupled nucleotide-excision repair,1
0,1,2,7,GO:0006284,base-excision repair,1
0,1,6,16,GO:0006289,nucleotide-excision repair,1
0,1,2,5,GO:0006298,mismatch repair,1
0,1,2,9,GO:0006301,postreplication repair,1
0,1,5,18,GO:0006309;GO:0000737;GO:0006308,DNA catabolic process,1
0,1,2,6,GO:0006312,mitotic recombination,1
0,1,4,7,GO:0006313;GO:0032196,transposition,
0,1,4,11,GO:0006333,chromatin assembly or disassembly,1
0,1,3,27,GO:0006334;GO:0065004,protein-DNA complex assembly,1
0,1,5,8,GO:0006337;GO:0032986,protein-DNA complex disassembly,1
0,1,4,48,GO:0006338,chromatin remodeling,1
0,1,4,33,GO:0006352,DNA-templated transcription,
0,1,2,14,GO:0006353,DNA-templated transcription,
0,1,2,4,GO:0006361,transcription initiation from RNA polymerase I promoter,1
0,1,2,15,GO:0006367,transcription initiation from RNA polymerase II promoter,1
0,1,3,13,GO:0006368;GO:0006354,DNA-templated transcription,
0,1,7,9,GO:0006369,termination of RNA polymerase II transcription,1
0,1,8,9,GO:0006370;GO:0009452;GO:0036260,7-methylguanosine mRNA capping,1
0,1,4,13,GO:0006376,mRNA splice site selection,1
0,1,3,12,GO:0006378;GO:0043631,RNA polyadenylation,1
0,1,2,5,GO:0006383,transcription by RNA polymerase III,1
0,1,3,80,GO:0006399,tRNA metabolic process,1
0,1,2,5,GO:0006400,tRNA modification,1
0,1,2,8,GO:0006403;GO:0008298,RNA localization,1
0,1,2,20,GO:0006406;GO:0006405,RNA export from nucleus,1
0,1,4,65,GO:0006412,translation,1
0,1,4,5,GO:0006414,translational elongation,1
0,1,3,51,GO:0006418;GO:0043039;GO:0043038,amino acid activation,1
0,1,2,4,GO:0006421,asparaginyl-tRNA aminoacylation,1
0,1,8,4,GO:0006422,aspartyl-tRNA aminoacylation,1
0,1,2,4,GO:0006428,isoleucyl-tRNA aminoacylation,1
0,1,8,5,GO:0006434,seryl-tRNA aminoacylation,1
0,1,9,4,GO:0006438,valyl-tRNA aminoacylation,1
0,1,2,4,GO:0006449,regulation of translational termination,1
0,1,2,6,GO:0006465,signal peptide processing,1
0,1,2,37,GO:0006470;GO:0016311,dephosphorylation,1
0,1,2,18,GO:0006471,protein ADP-ribosylation,1
0,1,3,66,GO:0006486;GO:0043413;GO:0070085,protein glycosylation,1
0,1,3,6,GO:0006488;GO:0006490,oligosaccharide-lipid intermediate biosynthetic process,1
0,1,2,16,GO:0006493,protein O-linked glycosylation,1
0,1,2,16,GO:0006497,protein lipidation,1
0,1,6,4,GO:0006499;GO:0006498;GO:0018377;GO:0009249,protein lipoylation,1
0,1,6,8,GO:0006506;GO:0006505;GO:0009247,GPI anchor metabolic process,1
0,1,3,12,GO:0006513,protein monoubiquitination,1
0,1,5,5,GO:0006515,protein quality control for misfolded or incompletely synthesized proteins,1
0,1,8,6,GO:0006525,arginine metabolic process,1
0,1,2,4,GO:0006526,arginine biosynthetic process,1
0,1,6,5,GO:0006547;GO:0052803,histidine metabolic process,1
0,1,7,9,GO:0006559;GO:0006558;GO:1902222;GO:1902221;GO:0006570;GO:0006572,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,1
0,1,7,7,GO:0006561;GO:0006560,proline metabolic process,1
0,1,2,7,GO:0006563,L-serine metabolic process,1
0,1,2,5,GO:0006564,L-serine biosynthetic process,1
0,1,4,11,GO:0006576;GO:0044106,cellular biogenic amine metabolic process,1
0,1,2,4,GO:0006577,amino-acid betaine metabolic process,1
0,1,4,4,GO:0006582,melanin metabolic process,1
0,1,5,24,GO:0006584;GO:0009712,catechol-containing compound metabolic process,1
0,1,3,6,GO:0006596;GO:0006595;GO:0042401;GO:0009309,cellular biogenic amine biosynthetic process,1
0,1,3,40,GO:0006606;GO:0017038;GO:0034504;GO:0051170,protein import,1
0,1,6,8,GO:0006607;GO:0006610,NLS-bearing protein import into nucleus,1
0,1,2,6,GO:0006614;GO:0006613,cotranslational protein targeting to membrane,1
0,1,2,6,GO:0006622;GO:0061462,protein targeting to lysosome,1
0,1,6,9,GO:0006623;GO:0072666;GO:0072665,protein localization to vacuole,1
0,1,3,9,GO:0006626,protein targeting to mitochondrion,1
0,1,2,20,GO:0006635;GO:0009062;GO:0019395;GO:0034440,fatty acid oxidation,1
0,1,2,13,GO:0006637;GO:0035383,acyl-CoA metabolic process,1
0,1,3,20,GO:0006641;GO:0006639;GO:0006638,acylglycerol metabolic process,1
0,1,3,36,GO:0006643,membrane lipid metabolic process,1
0,1,4,5,GO:0006654;GO:0046473,phosphatidic acid metabolic process,1
0,1,5,4,GO:0006656,phosphatidylcholine biosynthetic process,1
0,1,5,10,GO:0006661,phosphatidylinositol biosynthetic process,1
0,1,3,27,GO:0006662;GO:0018904,ether metabolic process,1
0,1,2,16,GO:0006664;GO:1903509,liposaccharide metabolic process,1
0,1,2,25,GO:0006665,sphingolipid metabolic process,1
0,1,3,4,GO:0006670;GO:0046519,sphingoid metabolic process,1
0,1,2,14,GO:0006672,ceramide metabolic process,1
0,1,3,6,GO:0006684,sphingomyelin metabolic process,1
0,1,2,35,GO:0006694,steroid biosynthetic process,1
0,1,3,9,GO:0006695;GO:0016126;GO:1902653,sterol biosynthetic process,1
0,1,3,10,GO:0006703,estrogen biosynthetic process,1
0,1,3,15,GO:0006720,isoprenoid metabolic process,1
0,1,5,4,GO:0006729,tetrahydrobiopterin biosynthetic process,1
0,1,4,7,GO:0006739,NADP metabolic process,1
0,1,3,8,GO:0006744;GO:0006743;GO:1901663;GO:0042181,ketone biosynthetic process,1
0,1,2,75,GO:0006754;GO:0009206;GO:0046034;GO:0009145;GO:0009201;GO:0009205;GO:0009142;GO:0009144;GO:0009199;GO:0009141,nucleoside triphosphate metabolic process,1
0,1,5,4,GO:0006784;GO:0046160,heme a metabolic process,1
0,1,2,20,GO:0006801,superoxide metabolic process,1
0,1,2,11,GO:0006805,xenobiotic metabolic process,1
0,1,7,10,GO:0006813,potassium ion transport,1
0,1,4,37,GO:0006814,sodium ion transport,1
0,1,8,25,GO:0006816,calcium ion transport,1
0,1,2,12,GO:0006825,copper ion transport,1
0,1,8,9,GO:0006826,iron ion transport,1
0,1,8,15,GO:0006829,zinc ion transport,1
0,1,2,7,GO:0006833;GO:0042044,fluid transport,1
0,1,2,4,GO:0006835,dicarboxylic acid transport,1
0,1,2,20,GO:0006836,neurotransmitter transport,1
0,1,2,26,GO:0006839,mitochondrial transport,1
0,1,5,4,GO:0006855,drug transmembrane transport,1
0,1,2,24,GO:0006865,amino acid transport,1
0,1,2,7,GO:0006878;GO:0055070,copper ion homeostasis,1
0,1,2,13,GO:0006879,cellular iron ion homeostasis,1
0,1,2,6,GO:0006884,cell volume homeostasis,1
0,1,4,33,GO:0006888,endoplasmic reticulum to Golgi vesicle-mediated transport,1
0,1,6,10,GO:0006890,retrograde vesicle-mediated transport,
0,1,6,7,GO:0006891,intra-Golgi vesicle-mediated transport,1
0,1,2,16,GO:0006895,Golgi to endosome transport,1
0,1,2,11,GO:0006901,vesicle coating,1
0,1,2,6,GO:0006903,vesicle targeting,1
0,1,2,16,GO:0006904;GO:0140029,exocytic process,1
0,1,2,34,GO:0006906;GO:0090174;GO:0048284;GO:0061025,organelle fusion,1
0,1,2,17,GO:0006909,phagocytosis,1
0,1,3,4,GO:0006910,phagocytosis,
0,1,6,11,GO:0006911;GO:0099024;GO:0010324,phagocytosis,
0,1,3,37,GO:0006914;GO:0061919,autophagy,1
0,1,8,24,GO:0006919,activation of cysteine-type endopeptidase activity involved in apoptotic process,1
0,1,2,10,GO:0006921,cellular component disassembly involved in execution phase of apoptosis,1
0,1,2,5,GO:0006931;GO:0032023;GO:0031638,trypsinogen activation,1
0,1,3,31,GO:0006935;GO:0042330,taxis,1
0,1,4,34,GO:0006936;GO:0003012,muscle system process,1
0,1,2,4,GO:0006937,regulation of muscle contraction,1
0,1,5,7,GO:0006939,smooth muscle contraction,1
0,1,5,17,GO:0006941,striated muscle contraction,1
0,1,4,17,GO:0006953;GO:0002526,acute inflammatory response,1
0,1,7,18,GO:0006957;GO:0006956,complement activation,1
0,1,2,7,GO:0006958,complement activation,
0,1,3,8,GO:0006970,response to osmotic stress,1
0,1,7,13,GO:0006977;GO:0072431;GO:1902400;GO:1902402;GO:0072422;GO:1902403;GO:0072401;GO:0072413;GO:0072395;GO:0051437;GO:0006521;GO:0033238,obsolete positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,1
0,1,3,7,GO:0006983,ER overload response,1
0,1,2,17,GO:0006984,ER-nucleus signaling pathway,1
0,1,2,4,GO:0006997,nucleus organization,1
0,1,4,11,GO:0007006,mitochondrial membrane organization,1
0,1,3,5,GO:0007016,cytoskeletal anchoring at plasma membrane,1
0,1,5,5,GO:0007020,microtubule nucleation,1
0,1,2,5,GO:0007029,endoplasmic reticulum organization,1
0,1,2,45,GO:0007030,Golgi organization,1
0,1,2,10,GO:0007031,peroxisome organization,1
0,1,9,5,GO:0007035;GO:0051452;GO:0045851,vacuolar acidification,1
0,1,2,24,GO:0007043;GO:0045216,cell-cell junction organization,1
0,1,5,25,GO:0007044,cell-substrate junction assembly,1
0,1,2,40,GO:0007059,chromosome segregation,1
0,1,3,6,GO:0007062,sister chromatid cohesion,1
0,1,2,13,GO:0007076,mitotic chromosome condensation,1
0,1,-1,6,GO:0007090,obsolete regulation of S phase of mitotic cell cycle,1
0,1,7,10,GO:0007094;GO:0045841;GO:0071173;GO:0071174;GO:1902100;GO:2000816;GO:0031577;GO:0033048;GO:1905819;GO:0033046;GO:0045839;GO:0051985,spindle checkpoint,1
0,1,5,5,GO:0007095,mitotic G2 DNA damage checkpoint,1
0,1,2,10,GO:0007097;GO:0051647,nuclear migration,1
0,1,4,8,GO:0007140;GO:0140013;GO:0000280,meiotic nuclear division,1
0,1,3,5,GO:0007159,leukocyte cell-cell adhesion,1
0,1,4,22,GO:0007160,cell-matrix adhesion,1
0,1,4,26,GO:0007173;GO:0038127,epidermal growth factor receptor signaling pathway,1
0,1,2,31,GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway,1
0,1,3,22,GO:0007179,transforming growth factor beta receptor signaling pathway,1
0,1,2,5,GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway,1
0,1,2,4,GO:0007200,phospholipase C-activating G protein-coupled receptor signaling pathway,1
0,1,2,17,GO:0007204;GO:0051480,regulation of cytosolic calcium ion concentration,1
0,1,2,13,GO:0007213;GO:0095500;GO:1903831,G protein-coupled acetylcholine receptor signaling pathway,1
0,1,2,5,GO:0007214,gamma-aminobutyric acid signaling pathway,1
0,1,2,10,GO:0007215,glutamate receptor signaling pathway,1
0,1,6,4,GO:0007223,Wnt signaling pathway,
0,1,3,6,GO:0007224,smoothened signaling pathway,1
0,1,3,33,GO:0007229,integrin-mediated signaling pathway,1
0,1,2,11,GO:0007249,I-kappaB kinase/NF-kappaB signaling,1
0,1,2,4,GO:0007252,I-kappaB phosphorylation,1
0,1,2,18,GO:0007254,JNK cascade,1
0,1,7,14,GO:0007257,activation of JUN kinase activity,1
0,1,2,9,GO:0007269,neurotransmitter secretion,1
0,1,4,13,GO:0007274,neuromuscular synaptic transmission,1
0,1,4,7,GO:0007301;GO:0030725;GO:0043063;GO:0030723,intercellular bridge organization,1
0,1,3,14,GO:0007338;GO:0009566,fertilization,1
0,1,2,5,GO:0007362,terminal region determination,1
0,1,4,15,GO:0007368;GO:0009855;GO:0009799,determination of left/right symmetry,1
0,1,4,13,GO:0007369,gastrulation,1
0,1,2,5,GO:0007380;GO:0007379,segment specification,1
0,1,3,4,GO:0007395,dorsal closure,
0,1,4,79,GO:0007399,nervous system development,1
0,1,3,4,GO:0007405,neuroblast proliferation,1
0,1,4,6,GO:0007416,synapse assembly,1
0,1,4,41,GO:0007417,central nervous system development,1
0,1,5,11,GO:0007424;GO:0060541,open tracheal system development,1
0,1,2,6,GO:0007431,salivary gland development,1
0,1,3,9,GO:0007435;GO:0022612,salivary gland morphogenesis,1
0,1,2,6,GO:0007476;GO:0035114;GO:0035120,imaginal disc-derived appendage morphogenesis,1
0,1,2,40,GO:0007507,heart development,1
0,1,5,5,GO:0007512,adult heart development,1
0,1,3,19,GO:0007517;GO:0061061,muscle structure development,1
0,1,2,5,GO:0007520;GO:0000768;GO:0006949;GO:0140253,myoblast fusion,1
0,1,3,4,GO:0007530,sex determination,1
0,1,3,8,GO:0007548,sex differentiation,1
0,1,2,9,GO:0007566,embryo implantation,1
0,1,2,28,GO:0007568,aging,1
0,1,3,11,GO:0007569,cell aging,1
0,1,3,17,GO:0007584,response to nutrient,1
0,1,2,11,GO:0007585,respiratory gaseous exchange,1
0,1,2,15,GO:0007586,digestion,1
0,1,4,10,GO:0007589,body fluid secretion,1
0,1,2,7,GO:0007595,lactation,1
0,1,2,53,GO:0007596;GO:0007599;GO:0050817,blood coagulation,1
0,1,4,4,GO:0007602,phototransduction,1
0,1,2,47,GO:0007605;GO:0050954,sensory perception of sound,1
0,1,2,14,GO:0007608;GO:0007606,sensory perception of chemical stimulus,1
0,1,2,14,GO:0007612,learning,1
0,1,3,10,GO:0007617;GO:0019098,reproductive behavior,1
0,1,4,6,GO:0007619;GO:0042023;GO:0044786;GO:0008258;GO:0007485;GO:0007484;GO:0030717;GO:0061988;GO:0046960;GO:0046958,courtship behavior,1
0,1,2,12,GO:0007623,circadian rhythm,1
0,1,2,12,GO:0007631,feeding behavior,1
0,1,4,6,GO:0007632,visual behavior,1
0,1,2,17,GO:0007635,chemosensory behavior,1
0,1,2,7,GO:0007638,mechanosensory behavior,1
0,1,4,4,GO:0008015,blood circulation,1
0,1,2,30,GO:0008033,tRNA processing,1
0,1,4,17,GO:0008088,axo-dendritic transport,1
0,1,2,9,GO:0008154;GO:0030041,actin polymerization or depolymerization,1
0,1,2,5,GO:0008156,negative regulation of DNA replication,1
0,1,5,5,GO:0008207,C21-steroid hormone metabolic process,1
0,1,5,4,GO:0008209,androgen metabolic process,1
0,1,5,16,GO:0008210,estrogen metabolic process,1
0,1,2,16,GO:0008217,regulation of blood pressure,1
0,1,3,7,GO:0008293,torso signaling pathway,1
0,1,2,8,GO:0008299,isoprenoid biosynthetic process,1
0,1,3,8,GO:0008306,associative learning,1
0,1,3,10,GO:0008344,adult locomotory behavior,1
0,1,3,9,GO:0008354,germ cell migration,1
0,1,6,4,GO:0008355,olfactory learning,1
0,1,2,18,GO:0008361,regulation of cell size,1
0,1,2,7,GO:0008535,respiratory chain complex IV assembly,1
0,1,6,4,GO:0008542,visual learning,1
0,1,3,29,GO:0008543,fibroblast growth factor receptor signaling pathway,1
0,1,6,7,GO:0008582;GO:1904396,regulation of neuromuscular junction development,1
0,1,3,11,GO:0008589,regulation of smoothened signaling pathway,1
0,1,5,6,GO:0008615;GO:0008614;GO:0042819;GO:0042816,vitamin B6 biosynthetic process,1
0,1,-1,7,GO:0008633,obsolete activation of pro-apoptotic gene products,1
0,1,-1,4,GO:0008634,obsolete negative regulation of survival gene product expression,1
0,1,10,5,GO:0008635,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,1
0,1,3,6,GO:0008637,apoptotic mitochondrial changes,1
0,1,2,6,GO:0008643,carbohydrate transport,1
0,1,6,5,GO:0009051;GO:0051156,glucose 6-phosphate metabolic process,1
0,1,3,5,GO:0009060;GO:0045333,aerobic respiration,1
0,1,7,9,GO:0009065,glutamine family amino acid catabolic process,1
0,1,5,18,GO:0009072,aromatic amino acid family metabolic process,1
0,1,3,5,GO:0009073,aromatic amino acid family biosynthetic process,1
0,1,4,13,GO:0009074,aromatic amino acid family catabolic process,1
0,1,6,12,GO:0009081,branched-chain amino acid metabolic process,1
0,1,2,8,GO:0009083,branched-chain amino acid catabolic process,1
0,1,3,5,GO:0009101,glycoprotein biosynthetic process,1
0,1,2,63,GO:0009108,coenzyme biosynthetic process,1
0,1,2,25,GO:0009112,nucleobase metabolic process,1
0,1,2,6,GO:0009113,purine nucleobase biosynthetic process,1
0,1,4,34,GO:0009116;GO:1901657,glycosyl compound metabolic process,1
0,1,5,184,GO:0009117;GO:0006753;GO:0055086,nucleobase-containing small molecule metabolic process,1
0,1,2,4,GO:0009147,pyrimidine nucleoside triphosphate metabolic process,1
0,1,6,139,GO:0009150;GO:0006163;GO:0009259;GO:0072521;GO:0019693,purine-containing compound metabolic process,1
0,1,3,119,GO:0009152;GO:0006164;GO:0009260;GO:0009165;GO:0072522;GO:0046390;GO:1901293,nucleoside phosphate biosynthetic process,1
0,1,3,7,GO:0009154;GO:0006195;GO:0009261;GO:0072523,ribonucleotide catabolic process,1
0,1,4,13,GO:0009156;GO:0009124;GO:0009161;GO:0009123,nucleoside monophosphate biosynthetic process,1
0,1,2,10,GO:0009163;GO:1901659,nucleoside biosynthetic process,1
0,1,5,14,GO:0009164;GO:0034656;GO:1901658,nucleobase-containing small molecule catabolic process,1
0,1,2,10,GO:0009187,cyclic nucleotide metabolic process,1
0,1,4,9,GO:0009220;GO:0009218,pyrimidine ribonucleotide metabolic process,1
0,1,2,4,GO:0009262,deoxyribonucleotide metabolic process,1
0,1,3,9,GO:0009303;GO:0098781,rRNA transcription,1
0,1,2,15,GO:0009308,amine metabolic process,1
0,1,2,7,GO:0009311,oligosaccharide metabolic process,1
0,1,5,4,GO:0009312,oligosaccharide biosynthetic process,1
0,1,5,16,GO:0009395,phospholipid catabolic process,1
0,1,4,4,GO:0009396,folic acid-containing compound biosynthetic process,1
0,1,3,13,GO:0009405,pathogenesis,1
0,1,3,25,GO:0009408,response to heat,1
0,1,3,10,GO:0009410,response to xenobiotic stimulus,1
0,1,3,4,GO:0009435;GO:0019674,NAD biosynthetic process,1
0,1,2,23,GO:0009451,RNA modification,1
0,1,2,18,GO:0009581;GO:0009582,detection of abiotic stimulus,1
0,1,2,7,GO:0009583,detection of light stimulus,1
0,1,2,5,GO:0009597,detection of virus,1
0,1,3,4,GO:0009620,response to fungus,1
0,1,2,4,GO:0009629,response to gravity,1
0,1,2,38,GO:0009636,response to toxic substance,1
0,1,4,5,GO:0009651,response to salt stress,1
0,1,3,5,GO:0009664;GO:0071555;GO:0071669;GO:0045229;GO:0071554,external encapsulating structure organization,1
0,1,4,23,GO:0009749;GO:0009746;GO:0034284;GO:0009743,response to carbohydrate,1
0,1,2,5,GO:0009751,response to salicylic acid,1
0,1,4,4,GO:0009753,response to jasmonic acid,1
0,1,2,45,GO:0009791,post-embryonic development,1
0,1,2,5,GO:0009826,unidimensional cell growth,1
0,1,2,7,GO:0009847,spore germination,1
0,1,3,15,GO:0009880,embryonic pattern specification,1
0,1,4,4,GO:0009908;GO:0090567;GO:0048367,shoot system development,1
0,1,2,7,GO:0009913,epidermal cell differentiation,1
0,1,2,11,GO:0009914;GO:0046879,hormone transport,1
0,1,4,7,GO:0009950,dorsal/ventral axis specification,1
0,1,4,20,GO:0010001,glial cell differentiation,1
0,1,5,4,GO:0010002,cardioblast differentiation,1
0,1,2,6,GO:0010039,response to iron ion,1
0,1,2,12,GO:0010171,body morphogenesis,1
0,1,4,5,GO:0010172,embryonic body morphogenesis,1
0,1,2,4,GO:0010225,response to UV-C,1
0,1,3,5,GO:0010259,multicellular organism aging,1
0,1,7,10,GO:0010389;GO:1902749,regulation of G2/M transition of mitotic cell cycle,1
0,1,5,14,GO:0010517;GO:0060191,regulation of lipase activity,1
0,1,6,8,GO:0010518;GO:0060193,positive regulation of phospholipase activity,1
0,1,4,5,GO:0010522;GO:1903169,regulation of calcium ion transport into cytosol,1
0,1,5,5,GO:0010571;GO:0033262;GO:2000105;GO:0070914,regulation of nuclear cell cycle DNA replication,1
0,1,3,4,GO:0010595;GO:0010594,regulation of endothelial cell migration,1
0,1,3,4,GO:0010611;GO:0014743;GO:0043502,regulation of cardiac muscle hypertrophy,1
0,1,4,6,GO:0010633,negative regulation of epithelial cell migration,1
0,1,5,20,GO:0010634,positive regulation of epithelial cell migration,1
0,1,2,28,GO:0010638,positive regulation of organelle organization,1
0,1,2,58,GO:0010639,negative regulation of organelle organization,1
0,1,3,4,GO:0010669,epithelial structure maintenance,1
0,1,3,11,GO:0010675;GO:0043255;GO:0010906,regulation of cellular carbohydrate metabolic process,1
0,1,2,5,GO:0010761,fibroblast migration,1
0,1,2,6,GO:0010812,negative regulation of cell-substrate adhesion,1
0,1,3,96,GO:0010817,regulation of hormone levels,1
0,1,2,6,GO:0010821,regulation of mitochondrion organization,1
0,1,3,24,GO:0010827,regulation of glucose transmembrane transport,1
0,1,4,4,GO:0010830;GO:0051153,regulation of myotube differentiation,1
0,1,2,4,GO:0010863;GO:1900274,positive regulation of phospholipase C activity,1
0,1,3,8,GO:0010867;GO:0010866;GO:0046889,regulation of triglyceride biosynthetic process,1
0,1,3,5,GO:0010912;GO:0010911,regulation of isomerase activity,1
0,1,3,18,GO:0010959,regulation of metal ion transport,1
0,1,3,30,GO:0010970;GO:0030705;GO:0099111,transport along microtubule,1
0,1,2,24,GO:0014013;GO:0045685,regulation of gliogenesis,1
0,1,2,21,GO:0014014;GO:0045686;GO:0048710,negative regulation of gliogenesis,1
0,1,5,11,GO:0014032;GO:0014031;GO:0048667;GO:0090102;GO:0061009;GO:0021555;GO:0030857;GO:0045604;GO:0003151;GO:0003266,regulation of epidermal cell differentiation,1
0,1,2,5,GO:0014066,regulation of phosphatidylinositol 3-kinase signaling,1
0,1,2,76,GO:0014070,response to organic cyclic compound,1
0,1,5,15,GO:0014074;GO:0046683,response to purine-containing compound,1
0,1,5,6,GO:0014075,response to amine,1
0,1,2,4,GO:0014902,myotube differentiation,1
0,1,4,7,GO:0015669,gas transport,1
0,1,5,4,GO:0015671,oxygen transport,1
0,1,2,5,GO:0015696,ammonium transport,1
0,1,3,5,GO:0015698,inorganic anion transport,1
0,1,2,6,GO:0015701,bicarbonate transport,1
0,1,2,12,GO:0015718,monocarboxylic acid transport,1
0,1,4,4,GO:0015809;GO:0015802,arginine transport,1
0,1,5,5,GO:0015844,monoamine transport,1
0,1,2,23,GO:0015893,drug transport,1
0,1,2,6,GO:0015908,fatty acid transport,1
0,1,4,4,GO:0015909;GO:1902001,long-chain fatty acid transport,1
0,1,5,7,GO:0015919;GO:0016558;GO:0044743,peroxisomal membrane transport,1
0,1,6,8,GO:0015936,coenzyme A metabolic process,1
0,1,2,4,GO:0015937,coenzyme A biosynthetic process,1
0,1,8,12,GO:0015986;GO:0015985,energy coupled proton transport,
0,1,6,25,GO:0015991;GO:0015988;GO:0099131;GO:0099132;GO:0090662,ATP hydrolysis coupled ion transmembrane transport,1
0,1,3,69,GO:0016032;GO:0044403,symbiont process,1
0,1,2,43,GO:0016052,carbohydrate catabolic process,1
0,1,2,4,GO:0016082,synaptic vesicle priming,1
0,1,2,5,GO:0016189,synaptic vesicle to endosome fusion,1
0,1,3,27,GO:0016199;GO:0016198,axon midline choice point recognition,1
0,1,2,16,GO:0016202;GO:0048634;GO:1901861,regulation of muscle organ development,1
0,1,4,10,GO:0016226;GO:0031163,iron-sulfur cluster assembly,1
0,1,2,4,GO:0016319,mushroom body development,1
0,1,2,7,GO:0016332,establishment or maintenance of polarity of embryonic epithelium,1
0,1,2,8,GO:0016334,establishment or maintenance of polarity of follicular epithelium,1
0,1,5,4,GO:0016338,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,1
0,1,5,4,GO:0016339,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,1
0,1,2,4,GO:0016358,dendrite development,1
0,1,5,5,GO:0016447;GO:0002562;GO:0016445;GO:0002200;GO:0016444,somatic diversification of immunoglobulins,1
0,1,2,11,GO:0016486,peptide hormone processing,1
0,1,4,16,GO:0016525;GO:2000181;GO:1901343,negative regulation of vasculature development,1
0,1,3,4,GO:0016559,peroxisome fission,1
0,1,6,4,GO:0016576,histone dephosphorylation,1
0,1,2,8,GO:0016578,histone deubiquitination,1
0,1,8,12,GO:0016925,protein sumoylation,1
0,1,4,5,GO:0016998;GO:0044036,cell wall macromolecule metabolic process,1
0,1,4,7,GO:0017000,antibiotic biosynthetic process,1
0,1,2,11,GO:0017004,cytochrome complex assembly,1
0,1,6,12,GO:0017156;GO:0016079,calcium ion regulated exocytosis,1
0,1,2,21,GO:0017157,regulation of exocytosis,1
0,1,2,6,GO:0017158,regulation of calcium ion-dependent exocytosis,1
0,1,2,7,GO:0018065,protein-cofactor linkage,1
0,1,2,5,GO:0018106;GO:0018202,peptidyl-histidine modification,1
0,1,4,22,GO:0018108;GO:0018212,peptidyl-tyrosine phosphorylation,1
0,1,2,5,GO:0018126,protein hydroxylation,1
0,1,2,10,GO:0018149,peptide cross-linking,1
0,1,6,8,GO:0018200,peptidyl-glutamic acid modification,1
0,1,2,5,GO:0018210,peptidyl-threonine modification,1
0,1,2,33,GO:0018279;GO:0006487;GO:0018196,protein N-linked glycosylation,1
0,1,2,14,GO:0018298,protein-chromophore linkage,1
0,1,3,5,GO:0018410,C-terminal protein amino acid modification,1
0,1,4,34,GO:0018958,phenol-containing compound metabolic process,1
0,1,5,4,GO:0019046,release from viral latency,1
0,1,2,7,GO:0019058,viral life cycle,1
0,1,2,9,GO:0019218,regulation of steroid metabolic process,1
0,1,2,35,GO:0019221,cytokine-mediated signaling pathway,1
0,1,5,7,GO:0019227;GO:0098870,action potential propagation,1
0,1,5,5,GO:0019228,neuronal action potential,1
0,1,6,7,GO:0019229,regulation of vasoconstriction,1
0,1,2,84,GO:0019318;GO:0005996,monosaccharide metabolic process,1
0,1,3,4,GO:0019320;GO:0046365,monosaccharide catabolic process,1
0,1,2,4,GO:0019370,leukotriene biosynthetic process,1
0,1,3,5,GO:0019377,glycolipid catabolic process,1
0,1,2,7,GO:0019430;GO:0098869;GO:1990748;GO:0098754,removal of superoxide radicals,1
0,1,4,5,GO:0019695,choline metabolic process,1
0,1,2,15,GO:0019722,calcium-mediated signaling,1
0,1,2,11,GO:0019748,secondary metabolic process,1
0,1,2,8,GO:0019835,cytolysis,1
0,1,3,6,GO:0019852,L-ascorbic acid metabolic process,1
0,1,3,8,GO:0019884;GO:0002478,antigen processing and presentation of exogenous antigen,1
0,1,3,7,GO:0019915,lipid storage,1
0,1,3,27,GO:0019932,second-messenger-mediated signaling,1
0,1,5,11,GO:0019933;GO:0019935,cAMP-mediated signaling,1
0,1,2,5,GO:0019985,translesion synthesis,1
0,1,-1,4,GO:0019987,obsolete negative regulation of anti-apoptosis,1
0,1,3,4,GO:0021501,prechordal plate formation,1
0,1,3,4,GO:0021508,floor plate formation,1
0,1,2,11,GO:0021510,spinal cord development,1
0,1,2,9,GO:0021515,cell differentiation in spinal cord,1
0,1,3,8,GO:0021537,telencephalon development,1
0,1,3,8,GO:0021545;GO:0021675,nerve development,1
0,1,3,7,GO:0021549,cerebellum development,1
0,1,3,4,GO:0021587,cerebellum morphogenesis,1
0,1,2,5,GO:0021670,lateral ventricle development,1
0,1,2,4,GO:0021680,cerebellar Purkinje cell layer development,1
0,1,3,4,GO:0021695,cerebellar cortex development,1
0,1,5,4,GO:0021702,cerebellar Purkinje cell differentiation,1
0,1,4,5,GO:0021744;GO:0048857,neural nucleus development,1
0,1,4,11,GO:0021782,glial cell development,1
0,1,3,6,GO:0021794,thalamus development,1
0,1,2,4,GO:0021854,hypothalamus development,1
0,1,6,6,GO:0021861;GO:0060019;GO:2000978;GO:2000977,radial glial cell differentiation,1
0,1,7,4,GO:0021873;GO:0055057;GO:0036445;GO:0048103,forebrain neuroblast division,1
0,1,6,14,GO:0021884;GO:0021954,central nervous system neuron development,1
0,1,2,9,GO:0021891,olfactory bulb interneuron development,1
0,1,2,4,GO:0021915,neural tube development,1
0,1,4,6,GO:0021952;GO:0021955,central nervous system projection neuron axonogenesis,1
0,1,2,4,GO:0021983,pituitary gland development,1
0,1,4,12,GO:0022008,neurogenesis,1
0,1,4,6,GO:0022011;GO:0032292,peripheral nervous system axon ensheathment,1
0,1,3,4,GO:0022027,interkinetic nuclear migration,1
0,1,3,4,GO:0022038,corpus callosum development,1
0,1,2,49,GO:0022403;GO:0044848,biological phase,1
0,1,3,10,GO:0022405;GO:0022404,hair cycle process,1
0,1,3,35,GO:0022411,cellular component disassembly,1
0,1,2,22,GO:0022602,ovulation cycle process,1
0,1,2,24,GO:0022613;GO:0044085;GO:0042254,cellular component biogenesis,1
0,1,3,5,GO:0022617;GO:0071800,podosome assembly,1
0,1,3,8,GO:0022898;GO:0032409;GO:0032411,regulation of transmembrane transporter activity,1
0,1,3,6,GO:0023035,CD40 signaling pathway,1
0,1,5,26,GO:0023061,signal release,1
0,1,3,29,GO:0030010,establishment of cell polarity,1
0,1,6,12,GO:0030032;GO:0097581,lamellipodium assembly,1
0,1,6,6,GO:0030042;GO:0051261,protein depolymerization,1
0,1,3,22,GO:0030048,actin filament-based movement,1
0,1,2,7,GO:0030049,muscle filament sliding,1
0,1,5,6,GO:0030072;GO:0030073,peptide hormone secretion,1
0,1,2,25,GO:0030098,lymphocyte differentiation,1
0,1,2,23,GO:0030100,regulation of endocytosis,1
0,1,3,8,GO:0030148,sphingolipid biosynthetic process,1
0,1,3,12,GO:0030149;GO:0046466,membrane lipid catabolic process,1
0,1,3,7,GO:0030174,regulation of DNA-dependent DNA replication initiation,1
0,1,3,26,GO:0030178,negative regulation of Wnt signaling pathway,1
0,1,5,12,GO:0030183,B cell differentiation,1
0,1,2,12,GO:0030199,collagen fibril organization,1
0,1,2,15,GO:0030203,glycosaminoglycan metabolic process,1
0,1,5,16,GO:0030217,T cell differentiation,1
0,1,2,7,GO:0030218,erythrocyte differentiation,1
0,1,3,25,GO:0030258,lipid modification,1
0,1,5,22,GO:0030261;GO:0006323,chromosome condensation,1
0,1,8,6,GO:0030263,apoptotic chromosome condensation,1
0,1,4,28,GO:0030278,regulation of ossification,1
0,1,2,7,GO:0030279,negative regulation of ossification,1
0,1,2,6,GO:0030282,bone mineralization,1
0,1,2,10,GO:0030307,positive regulation of cell growth,1
0,1,3,4,GO:0030317;GO:0097722,flagellated sperm motility,1
0,1,2,9,GO:0030323,respiratory tube development,1
0,1,2,5,GO:0030325,adrenal gland development,1
0,1,5,17,GO:0030326;GO:0035108,limb morphogenesis,1
0,1,2,19,GO:0030330;GO:0042770,signal transduction in response to DNA damage,1
0,1,3,15,GO:0030336;GO:2000146;GO:0051271,negative regulation of cellular component movement,1
0,1,2,4,GO:0030388,fructose 1,
0,1,2,4,GO:0030431,sleep,1
0,1,2,4,GO:0030490,maturation of SSU-rRNA,1
0,1,2,5,GO:0030497;GO:0042761;GO:0000038,fatty acid elongation,1
0,1,3,16,GO:0030500;GO:0070167,regulation of biomineral tissue development,1
0,1,3,17,GO:0030509,BMP signaling pathway,1
0,1,2,25,GO:0030510,regulation of BMP signaling pathway,1
0,1,4,10,GO:0030514,negative regulation of BMP signaling pathway,1
0,1,3,8,GO:0030574,collagen catabolic process,1
0,1,3,12,GO:0030595;GO:0060326;GO:0097529,cell chemotaxis,1
0,1,4,4,GO:0030714;GO:0060581;GO:0007318;GO:0045823;GO:0008016,cell fate commitment involved in pattern specification,1
0,1,3,4,GO:0030727;GO:0048135;GO:0007308;GO:0030707,female germ-line cyst formation,1
0,1,4,7,GO:0030838,positive regulation of actin filament polymerization,1
0,1,2,26,GO:0030856,regulation of epithelial cell differentiation,1
0,1,3,15,GO:0030858,positive regulation of epithelial cell differentiation,1
0,1,5,14,GO:0030866;GO:0030865,cortical actin cytoskeleton organization,1
0,1,2,7,GO:0030900,forebrain development,1
0,1,3,13,GO:0030901,midbrain development,1
0,1,2,5,GO:0030902,hindbrain development,1
0,1,2,4,GO:0030903,notochord development,1
0,1,5,5,GO:0030916,otic vesicle formation,1
0,1,3,10,GO:0030947,regulation of vascular endothelial growth factor receptor signaling pathway,1
0,1,2,7,GO:0030949,positive regulation of vascular endothelial growth factor receptor signaling pathway,1
0,1,2,5,GO:0030950,establishment or maintenance of actin cytoskeleton polarity,1
0,1,3,8,GO:0030952,establishment or maintenance of cytoskeleton polarity,1
0,1,3,20,GO:0030968,endoplasmic reticulum unfolded protein response,1
0,1,6,8,GO:0030970;GO:0032527;GO:1903513,retrograde protein transport,
0,1,3,15,GO:0031018,endocrine pancreas development,1
0,1,3,9,GO:0031023,microtubule organizing center organization,1
0,1,2,17,GO:0031032,actomyosin structure organization,1
0,1,5,23,GO:0031034;GO:0031033;GO:0030241;GO:0071688;GO:0010927,myosin filament assembly,1
0,1,8,5,GO:0031053;GO:0016246,RNA interference,1
0,1,2,4,GO:0031055,chromatin remodeling at centromere,1
0,1,3,5,GO:0031058;GO:0031056;GO:1905269;GO:2001252,positive regulation of chromosome organization,1
0,1,2,9,GO:0031076,embryonic camera-type eye development,1
0,1,2,12,GO:0031100;GO:0031099,regeneration,1
0,1,5,5,GO:0031103;GO:0031102;GO:0061564,neuron projection regeneration,1
0,1,6,16,GO:0031110,regulation of microtubule polymerization or depolymerization,1
0,1,4,7,GO:0031122,cytoplasmic microtubule organization,1
0,1,2,21,GO:0031124;GO:0031123,RNA 3'-end processing,1
0,1,6,8,GO:0031128;GO:1905332;GO:0090190;GO:0061213;GO:0090189;GO:0061217,regulation of mesonephros development,1
0,1,4,15,GO:0031145,anaphase-promoting complex-dependent catabolic process,1
0,1,2,41,GO:0031175,neuron projection development,1
0,1,2,5,GO:0031179,peptide modification,1
0,1,2,15,GO:0031214,biomineral tissue development,1
0,1,5,14,GO:0031290,retinal ganglion cell axon guidance,1
0,1,5,6,GO:0031293,membrane protein intracellular domain proteolysis,1
0,1,2,8,GO:0031295;GO:0031294,T cell costimulation,1
0,1,4,4,GO:0031343;GO:0031341,positive regulation of cell killing,1
0,1,2,8,GO:0031365,N-terminal protein amino acid modification,1
0,1,2,20,GO:0031424,keratinization,1
0,1,2,6,GO:0031497,chromatin assembly,1
0,1,4,4,GO:0031503,protein-containing complex localization,1
0,1,8,12,GO:0031572,G2 DNA damage checkpoint,1
0,1,2,16,GO:0031581,hemidesmosome assembly,1
0,1,3,45,GO:0031589,cell-substrate adhesion,1
0,1,2,10,GO:0031641,regulation of myelination,1
0,1,2,4,GO:0031643,positive regulation of myelination,1
0,1,3,21,GO:0031644,regulation of neurological system process,1
0,1,2,6,GO:0031645,negative regulation of neurological system process,1
0,1,3,9,GO:0031646,positive regulation of neurological system process,1
0,1,3,37,GO:0031667;GO:0009991,response to extracellular stimulus,1
0,1,2,9,GO:0031929,TOR signaling,1
0,1,3,4,GO:0031952,regulation of protein autophosphorylation,1
0,1,5,20,GO:0031960;GO:0048545,response to steroid hormone,1
0,1,2,16,GO:0032006,regulation of TOR signaling,1
0,1,2,7,GO:0032007,negative regulation of TOR signaling,1
0,1,2,7,GO:0032008,positive regulation of TOR signaling,1
0,1,6,8,GO:0032012,regulation of ARF protein signal transduction,1
0,1,2,4,GO:0032024,positive regulation of insulin secretion,1
0,1,2,4,GO:0032091,negative regulation of protein binding,1
0,1,2,16,GO:0032103,positive regulation of response to external stimulus,1
0,1,2,6,GO:0032148,activation of protein kinase B activity,1
0,1,4,4,GO:0032228,regulation of synaptic transmission,
0,1,4,6,GO:0032233,positive regulation of actin filament bundle assembly,1
0,1,6,12,GO:0032273;GO:0031334,positive regulation of protein complex assembly,1
0,1,2,16,GO:0032355,response to estradiol,1
0,1,5,14,GO:0032364;GO:0033483,gas homeostasis,1
0,1,2,7,GO:0032368,regulation of lipid transport,1
0,1,4,5,GO:0032374;GO:0032371,regulation of cholesterol transport,1
0,1,2,20,GO:0032386,regulation of intracellular transport,1
0,1,5,4,GO:0032388,positive regulation of intracellular transport,1
0,1,6,10,GO:0032438;GO:0048753,melanosome organization,1
0,1,2,7,GO:0032456,endocytic recycling,1
0,1,2,36,GO:0032496,response to lipopolysaccharide,1
0,1,2,19,GO:0032507;GO:0051651,maintenance of location in cell,1
0,1,2,5,GO:0032509;GO:0071985,multivesicular body sorting pathway,1
0,1,3,12,GO:0032606,type I interferon production,1
0,1,2,6,GO:0032608,interferon-beta production,1
0,1,2,23,GO:0032648,regulation of interferon-beta production,1
0,1,3,5,GO:0032649;GO:0032733;GO:0032653,regulation of interleukin-10 production,1
0,1,3,12,GO:0032655;GO:0032735,regulation of interleukin-12 production,1
0,1,4,6,GO:0032695,negative regulation of interleukin-12 production,1
0,1,6,8,GO:0032722;GO:0032642,positive regulation of chemokine production,1
0,1,3,14,GO:0032727;GO:0032481;GO:0032647;GO:0032728,positive regulation of type I interferon production,1
0,1,2,7,GO:0032743,positive regulation of interleukin-2 production,1
0,1,3,4,GO:0032781,positive regulation of ATPase activity,1
0,1,2,11,GO:0032784,regulation of DNA-templated transcription,
0,1,3,12,GO:0032801;GO:0001919,regulation of receptor recycling,1
0,1,4,18,GO:0032868,response to insulin,1
0,1,2,7,GO:0032869;GO:0046324,cellular response to insulin stimulus,1
0,1,2,15,GO:0032963,collagen metabolic process,1
0,1,2,5,GO:0032968;GO:0032786;GO:0034243,positive regulation of DNA-templated transcription,
0,1,7,6,GO:0032981;GO:0010257;GO:0033108,mitochondrial respiratory chain complex assembly,1
0,1,4,18,GO:0032984,protein-containing complex disassembly,1
0,1,2,4,GO:0033077,T cell differentiation in thymus,1
0,1,5,6,GO:0033135;GO:0033138,regulation of peptidyl-serine phosphorylation,1
0,1,3,4,GO:0033143,regulation of intracellular steroid hormone receptor signaling pathway,1
0,1,6,9,GO:0033157;GO:1903827,regulation of cellular protein localization,1
0,1,-1,4,GO:0033160,obsolete positive regulation of protein import into nucleus,
0,1,2,5,GO:0033198,response to ATP,1
0,1,2,4,GO:0033206,meiotic cytokinesis,1
0,1,4,15,GO:0033209,tumor necrosis factor-mediated signaling pathway,1
0,1,-1,6,GO:0033261,obsolete regulation of S phase,1
0,1,4,4,GO:0033273,response to vitamin,1
0,1,2,11,GO:0033275;GO:0070252,actin-mediated cell contraction,1
0,1,4,10,GO:0033334,fin morphogenesis,1
0,1,2,11,GO:0033559;GO:0006692,unsaturated fatty acid metabolic process,1
0,1,4,21,GO:0033875;GO:0034032;GO:0033865,ribonucleoside bisphosphate metabolic process,1
0,1,4,12,GO:0034030;GO:0034033;GO:0033866,nucleoside bisphosphate biosynthetic process,1
0,1,4,38,GO:0034097,response to cytokine,1
0,1,2,50,GO:0034220,ion transmembrane transport,1
0,1,2,6,GO:0034308,primary alcohol metabolic process,1
0,1,5,11,GO:0034311,diol metabolic process,1
0,1,4,52,GO:0034329;GO:0034330,cell junction organization,1
0,1,3,13,GO:0034332,adherens junction organization,1
0,1,-1,8,GO:0034339,obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor,1
0,1,5,5,GO:0034341,response to interferon-gamma,1
0,1,4,41,GO:0034404,nucleobase-containing small molecule biosynthetic process,1
0,1,3,6,GO:0034446,substrate adhesion-dependent cell spreading,1
0,1,4,10,GO:0034453,microtubule anchoring,1
0,1,4,23,GO:0034599,cellular response to oxidative stress,1
0,1,2,4,GO:0034605,cellular response to heat,1
0,1,2,11,GO:0034612,response to tumor necrosis factor,1
0,1,2,7,GO:0034614,cellular response to reactive oxygen species,1
0,1,3,6,GO:0034644;GO:0071482,cellular response to UV,1
0,1,4,40,GO:0034728;GO:0071824,protein-DNA complex subunit organization,1
0,1,2,25,GO:0034754,cellular hormone metabolic process,1
0,1,2,34,GO:0034762,regulation of transmembrane transport,1
0,1,2,18,GO:0034968;GO:0016571;GO:0018022;GO:0006479;GO:0008213,protein methylation,1
0,1,2,7,GO:0035019,somatic stem cell population maintenance,1
0,1,2,7,GO:0035050;GO:0008078,embryonic heart tube development,1
0,1,2,9,GO:0035051,cardiocyte differentiation,1
0,1,3,37,GO:0035107,appendage morphogenesis,1
0,1,2,7,GO:0035112,genitalia morphogenesis,1
0,1,4,20,GO:0035113,embryonic appendage morphogenesis,1
0,1,-1,9,GO:0035121,obsolete tail morphogenesis,1
0,1,5,4,GO:0035124;GO:0035122,embryonic medial fin morphogenesis,1
0,1,5,4,GO:0035138,pectoral fin morphogenesis,1
0,1,3,41,GO:0035148,tube formation,1
0,1,3,6,GO:0035152,regulation of tube architecture,
0,1,3,20,GO:0035176;GO:0051703,intraspecies interaction between organisms,1
0,1,4,7,GO:0035194;GO:0016441,posttranscriptional gene silencing,1
0,1,4,7,GO:0035235,ionotropic glutamate receptor signaling pathway,1
0,1,4,5,GO:0035249,synaptic transmission,
0,1,2,4,GO:0035264,multicellular organism growth,1
0,1,4,14,GO:0035278;GO:0040033;GO:0045974,negative regulation of translation,
0,1,4,12,GO:0035279;GO:0098795;GO:0006379;GO:0090501,mRNA cleavage,1
0,1,4,11,GO:0035282;GO:0001756,segmentation,1
0,1,7,11,GO:0035303,regulation of dephosphorylation,1
0,1,3,5,GO:0035315,hair cell differentiation,1
0,1,8,10,GO:0035338;GO:0035336;GO:0046949;GO:0035337;GO:0071616;GO:0035384;GO:0019432;GO:0046463;GO:0046460,acyl-CoA biosynthetic process,1
0,1,5,5,GO:0035419,activation of MAPK activity involved in innate immune response,1
0,1,2,5,GO:0035456,response to interferon-beta,1
0,1,2,6,GO:0035459,vesicle cargo loading,1
0,1,5,8,GO:0035567,non-canonical Wnt signaling pathway,1
0,1,5,15,GO:0035583;GO:0030512;GO:0035581;GO:0071694;GO:0017015;GO:1903845;GO:1903844;GO:1900116;GO:1900115,regulation of cellular response to transforming growth factor beta stimulus,1
0,1,5,4,GO:0035601;GO:0098732,macromolecule deacylation,1
0,1,3,8,GO:0035690,cellular response to drug,1
0,1,3,12,GO:0035821,modification of morphology or physiology of other organism,1
0,1,7,4,GO:0035829;GO:0070294;GO:0003096,renal sodium ion transport,1
0,1,4,4,GO:0035914,skeletal muscle cell differentiation,1
0,1,3,5,GO:0036230;GO:0042119;GO:0030854;GO:0030852,neutrophil activation,1
0,1,3,8,GO:0040001;GO:0051293;GO:0051653,establishment of spindle localization,1
0,1,4,9,GO:0040010;GO:0040009,regulation of growth rate,1
0,1,2,17,GO:0040013,negative regulation of locomotion,1
0,1,2,61,GO:0040017;GO:0030335;GO:2000147;GO:0051272,positive regulation of cellular component movement,1
0,1,2,5,GO:0040018,positive regulation of multicellular organism growth,1
0,1,2,5,GO:0040019,positive regulation of embryonic development,1
0,1,4,5,GO:0040020;GO:0051445,regulation of meiotic cell cycle,1
0,1,4,7,GO:0040024,dauer larval development,1
0,1,3,5,GO:0042036,negative regulation of cytokine biosynthetic process,1
0,1,2,8,GO:0042048,olfactory behavior,1
0,1,4,28,GO:0042058;GO:1901184,regulation of epidermal growth factor receptor signaling pathway,1
0,1,4,14,GO:0042059;GO:1901185,negative regulation of epidermal growth factor receptor signaling pathway,1
0,1,5,13,GO:0042062;GO:0048790;GO:0099558;GO:1990709;GO:0007026;GO:0031111;GO:0031114;GO:0030721,regulation of microtubule depolymerization,1
0,1,7,15,GO:0042102;GO:0050671;GO:0032946;GO:0070665,positive regulation of mononuclear cell proliferation,1
0,1,2,32,GO:0042110,T cell activation,1
0,1,2,22,GO:0042113,B cell activation,1
0,1,4,7,GO:0042136,neurotransmitter biosynthetic process,1
0,1,2,11,GO:0042147,retrograde transport,
0,1,4,8,GO:0042157,lipoprotein metabolic process,1
0,1,3,17,GO:0042180,cellular ketone metabolic process,1
0,1,4,5,GO:0042220;GO:0060359;GO:0072347;GO:0010288,response to anesthetic,1
0,1,5,7,GO:0042255,ribosome assembly,1
0,1,3,7,GO:0042359;GO:0006775,fat-soluble vitamin metabolic process,1
0,1,3,11,GO:0042364;GO:0009110,vitamin biosynthetic process,1
0,1,6,4,GO:0042402;GO:0009310,cellular biogenic amine catabolic process,1
0,1,4,4,GO:0042403,thyroid hormone metabolic process,1
0,1,2,4,GO:0042417,dopamine metabolic process,1
0,1,2,4,GO:0042430,indole-containing compound metabolic process,1
0,1,2,28,GO:0042440;GO:0046148,pigment metabolic process,1
0,1,2,53,GO:0042445,hormone metabolic process,1
0,1,3,28,GO:0042446,hormone biosynthetic process,1
0,1,4,12,GO:0042472,inner ear morphogenesis,1
0,1,2,6,GO:0042474;GO:0042473,middle ear morphogenesis,1
0,1,3,81,GO:0042493,response to drug,1
0,1,2,4,GO:0042534,regulation of tumor necrosis factor biosynthetic process,1
0,1,2,16,GO:0042542,response to hydrogen peroxide,1
0,1,3,10,GO:0042551,neuron maturation,1
0,1,2,17,GO:0042552;GO:0008366;GO:0007272,axon ensheathment,1
0,1,3,4,GO:0042554,superoxide anion generation,1
0,1,2,6,GO:0042559,pteridine-containing compound biosynthetic process,1
0,1,6,19,GO:0042593;GO:0033500,glucose homeostasis,1
0,1,3,20,GO:0042594;GO:0031669;GO:0031668;GO:0009267,response to starvation,1
0,1,3,22,GO:0042730;GO:0030195;GO:0030193;GO:0050819;GO:0061045;GO:1900047;GO:0050818;GO:1900046;GO:1903035,regulation of coagulation,1
0,1,4,4,GO:0042733,embryonic digit morphogenesis,1
0,1,3,12,GO:0042752,regulation of circadian rhythm,1
0,1,3,4,GO:0042832;GO:0001562,response to protozoan,1
0,1,5,6,GO:0042891,antibiotic transport,1
0,1,2,21,GO:0043010,camera-type eye development,1
0,1,5,8,GO:0043011;GO:0001773;GO:0097028;GO:0019886;GO:0002495;GO:0002504;GO:0070498;GO:0045084;GO:0031666,dendritic cell differentiation,1
0,1,4,37,GO:0043086,negative regulation of catalytic activity,1
0,1,3,5,GO:0043101,purine-containing compound salvage,1
0,1,2,4,GO:0043171,peptide catabolic process,1
0,1,3,5,GO:0043174,nucleoside salvage,1
0,1,2,20,GO:0043200,response to amino acid,1
0,1,2,4,GO:0043248,proteasome assembly,1
0,1,2,4,GO:0043252,sodium-independent organic anion transport,1
0,1,2,28,GO:0043269,regulation of ion transport,1
0,1,3,15,GO:0043270,positive regulation of ion transport,1
0,1,2,4,GO:0043271,negative regulation of ion transport,1
0,1,6,7,GO:0043277,apoptotic cell clearance,1
0,1,2,6,GO:0043279,response to alkaloid,1
0,1,3,33,GO:0043280;GO:0043281;GO:2001056;GO:2000116;GO:0052548;GO:0052547;GO:0010950;GO:0010952,regulation of peptidase activity,1
0,1,2,8,GO:0043388,positive regulation of DNA binding,1
0,1,5,5,GO:0043392,negative regulation of DNA binding,1
0,1,6,12,GO:0043407,negative regulation of MAP kinase activity,1
0,1,3,32,GO:0043434;GO:1901652,response to peptide,1
0,1,5,7,GO:0043462,regulation of ATPase activity,1
0,1,5,5,GO:0043486;GO:0043044,histone exchange,1
0,1,2,17,GO:0043488;GO:0043487;GO:0061013,regulation of mRNA catabolic process,1
0,1,3,4,GO:0043500,muscle adaptation,1
0,1,3,7,GO:0043508,negative regulation of JUN kinase activity,1
0,1,5,26,GO:0043524;GO:0043523;GO:1901215;GO:1901214,regulation of neuron death,1
0,1,3,5,GO:0043525;GO:1901216,positive regulation of neuron death,1
0,1,-1,7,GO:0043526,obsolete neuroprotection,1
0,1,6,8,GO:0043542,endothelial cell migration,1
0,1,6,4,GO:0043552;GO:0043551;GO:0090218;GO:1903727;GO:0043550;GO:1903725,regulation of lipid kinase activity,1
0,1,5,10,GO:0043574;GO:0065002;GO:0071806;GO:0006625;GO:0072663;GO:0072662,intracellular protein transmembrane transport,1
0,1,2,4,GO:0043583,ear development,1
0,1,2,4,GO:0043587,tongue morphogenesis,1
0,1,2,6,GO:0043588,skin development,1
0,1,5,9,GO:0043619;GO:0043618;GO:0043620;GO:0071347;GO:0002248;GO:0097709;GO:0051541;GO:0042789;GO:0009299;GO:0070101;GO:0001961;GO:0070099;GO:0060760;GO:0010870;GO:0010869;GO:0010575;GO:0010574;GO:0032909;GO:0071634;GO:0010573,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,1
0,1,5,9,GO:0043624,cellular protein complex disassembly,1
0,1,6,7,GO:0043666;GO:0010921;GO:0035304;GO:0035507,regulation of phosphatase activity,1
0,1,2,28,GO:0043687,post-translational protein modification,1
0,1,2,21,GO:0043902,positive regulation of multi-organism process,1
0,1,6,4,GO:0043928;GO:0000291,exonucleolytic catabolism of deadenylated mRNA,1
0,1,2,14,GO:0043954,cellular component maintenance,1
0,1,2,9,GO:0043966,histone H3 acetylation,1
0,1,2,12,GO:0043968,histone H2A acetylation,1
0,1,3,5,GO:0044003;GO:0051701,interaction with host,1
0,1,2,46,GO:0044057,regulation of system process,1
0,1,2,26,GO:0044089,positive regulation of cellular component biogenesis,1
0,1,3,6,GO:0044130;GO:0044126;GO:0044146;GO:0044144;GO:0071224;GO:0032494;GO:0050830;GO:0032660;GO:0032661;GO:0032760;GO:1903557,negative regulation of growth of symbiont in host,1
0,1,3,6,GO:0044179;GO:0051715;GO:0031640;GO:0001906;GO:0044364,cell killing,1
0,1,2,47,GO:0044242,cellular lipid catabolic process,1
0,1,2,4,GO:0044332,Wnt signaling pathway involved in dorsal/ventral axis specification,1
0,1,2,7,GO:0044550,secondary metabolite biosynthetic process,1
0,1,2,7,GO:0044703,multi-organism reproductive process,1
0,1,2,5,GO:0044706;GO:0007565,multi-multicellular organism process,1
0,1,8,7,GO:0044818;GO:0010972;GO:1902750,negative regulation of cell cycle G2/M phase transition,1
0,1,2,35,GO:0045017,glycerolipid biosynthetic process,1
0,1,6,6,GO:0045069;GO:1903900,regulation of viral life cycle,1
0,1,2,4,GO:0045071;GO:1903901,negative regulation of viral genome replication,1
0,1,2,8,GO:0045075,regulation of interleukin-12 biosynthetic process,1
0,1,3,22,GO:0045104;GO:0045103,intermediate filament cytoskeleton organization,1
0,1,4,5,GO:0045123;GO:0030593;GO:0071621;GO:1990266;GO:0097530,granulocyte chemotaxis,1
0,1,2,6,GO:0045132,meiotic chromosome segregation,1
0,1,3,23,GO:0045162;GO:0045161,neuronal ion channel clustering,1
0,1,3,4,GO:0045163,clustering of voltage-gated potassium channels,1
0,1,2,12,GO:0045176,apical protein localization,1
0,1,3,9,GO:0045198;GO:0030859;GO:0035089;GO:0061162;GO:0061339,polarized epithelial cell differentiation,1
0,1,5,5,GO:0045332;GO:0034204;GO:0097035,phospholipid translocation,1
0,1,5,6,GO:0045429;GO:0045428;GO:1903428;GO:1904407;GO:1903426,regulation of reactive oxygen species biosynthetic process,1
0,1,2,10,GO:0045446,endothelial cell differentiation,1
0,1,2,11,GO:0045453,bone resorption,1
0,1,3,69,GO:0045454,cell redox homeostasis,1
0,1,2,6,GO:0045471,response to ethanol,1
0,1,2,15,GO:0045478,fusome organization,1
0,1,4,5,GO:0045540;GO:0090181;GO:0106118;GO:1902930;GO:0050810,regulation of steroid biosynthetic process,1
0,1,3,14,GO:0045580;GO:0045619,regulation of T cell differentiation,1
0,1,4,6,GO:0045582;GO:0045621,positive regulation of T cell differentiation,1
0,1,2,11,GO:0045598,regulation of fat cell differentiation,1
0,1,3,5,GO:0045599,negative regulation of fat cell differentiation,1
0,1,4,14,GO:0045603;GO:0045601;GO:0048708;GO:0048709;GO:0046427;GO:1904894;GO:0002052;GO:2000179;GO:2000648;GO:0007221;GO:0042246,positive regulation of endothelial cell differentiation,1
0,1,3,4,GO:0045638,negative regulation of myeloid cell differentiation,1
0,1,2,10,GO:0045648;GO:0045646,regulation of erythrocyte differentiation,1
0,1,3,44,GO:0045666;GO:0010976;GO:0031346,positive regulation of neuron differentiation,1
0,1,2,19,GO:0045667,regulation of osteoblast differentiation,1
0,1,3,16,GO:0045669;GO:0045778,positive regulation of ossification,1
0,1,2,6,GO:0045682,regulation of epidermis development,1
0,1,4,13,GO:0045727;GO:0034250,positive regulation of cellular amide metabolic process,1
0,1,3,8,GO:0045736;GO:1904030,negative regulation of cyclin-dependent protein serine/threonine kinase activity,1
0,1,3,18,GO:0045740,positive regulation of DNA replication,1
0,1,3,8,GO:0045743,positive regulation of fibroblast growth factor receptor signaling pathway,1
0,1,4,12,GO:0045746,negative regulation of Notch signaling pathway,1
0,1,-1,8,GO:0045749,obsolete negative regulation of S phase of mitotic cell cycle,1
0,1,3,20,GO:0045766;GO:1904018,positive regulation of angiogenesis,1
0,1,-1,5,GO:0045768,obsolete positive regulation of anti-apoptosis,1
0,1,2,38,GO:0045787,positive regulation of cell cycle,1
0,1,4,5,GO:0045806;GO:0070086,ubiquitin-dependent endocytosis,1
0,1,3,11,GO:0045807,positive regulation of endocytosis,1
0,1,5,12,GO:0045821;GO:0006110;GO:0030813;GO:0045913;GO:0051197;GO:2001171;GO:0030811;GO:0043470;GO:0051196;GO:2001169;GO:0045981;GO:0062013;GO:0051194;GO:1900373;GO:1903580;GO:0051193;GO:1900371;GO:1903578;GO:0030810;GO:1900544;GO:0030808,regulation of cofactor metabolic process,1
0,1,3,4,GO:0045833;GO:0051055,negative regulation of lipid biosynthetic process,1
0,1,5,17,GO:0045834,positive regulation of lipid metabolic process,1
0,1,3,4,GO:0045840;GO:0051785,positive regulation of nuclear division,1
0,1,3,7,GO:0045879,negative regulation of smoothened signaling pathway,1
0,1,2,4,GO:0045880,positive regulation of smoothened signaling pathway,1
0,1,2,4,GO:0045907,positive regulation of vasoconstriction,1
0,1,3,5,GO:0045921,positive regulation of exocytosis,1
0,1,2,33,GO:0045927,positive regulation of growth,1
0,1,6,7,GO:0045931,positive regulation of mitotic cell cycle,1
0,1,3,27,GO:0045995,regulation of embryonic development,1
0,1,2,11,GO:0046006,regulation of activated T cell proliferation,1
0,1,2,7,GO:0046058,cAMP metabolic process,1
0,1,2,4,GO:0046068,cGMP metabolic process,1
0,1,2,13,GO:0046112,nucleobase biosynthetic process,1
0,1,4,5,GO:0046121;GO:0009120;GO:0006212;GO:0019860,uracil catabolic process,1
0,1,2,12,GO:0046128;GO:0009119;GO:0042278,ribonucleoside metabolic process,1
0,1,5,7,GO:0046129;GO:0042451;GO:0042455,ribonucleoside biosynthetic process,1
0,1,3,6,GO:0046146,tetrahydrobiopterin metabolic process,1
0,1,4,5,GO:0046184,aldehyde biosynthetic process,1
0,1,2,6,GO:0046189,phenol-containing compound biosynthetic process,1
0,1,3,4,GO:0046339,diacylglycerol metabolic process,1
0,1,3,11,GO:0046425;GO:1904892,regulation of receptor signaling pathway via STAT,1
0,1,2,53,GO:0046434,organophosphate catabolic process,1
0,1,3,11,GO:0046456,icosanoid biosynthetic process,1
0,1,6,6,GO:0046464;GO:0046461;GO:0046503;GO:0019433,acylglycerol catabolic process,1
0,1,2,15,GO:0046467,membrane lipid biosynthetic process,1
0,1,4,7,GO:0046470,phosphatidylcholine metabolic process,1
0,1,4,24,GO:0046474,glycerophospholipid biosynthetic process,1
0,1,2,48,GO:0046496;GO:0019362;GO:0006733;GO:0072524,pyridine-containing compound metabolic process,1
0,1,3,6,GO:0046500,S-adenosylmethionine metabolic process,1
0,1,2,6,GO:0046529,imaginal disc fusion,
0,1,3,11,GO:0046579;GO:0051057,positive regulation of Ras protein signal transduction,1
0,1,3,9,GO:0046580;GO:0051058,negative regulation of Ras protein signal transduction,1
0,1,2,4,GO:0046607;GO:0046605,positive regulation of centrosome cycle,1
0,1,2,14,GO:0046620,regulation of organ growth,1
0,1,2,4,GO:0046621,negative regulation of organ growth,1
0,1,3,9,GO:0046622,positive regulation of organ growth,1
0,1,6,17,GO:0046637;GO:0046634;GO:0033962;GO:0046007;GO:0042130;GO:0050672;GO:0050868;GO:0032945;GO:1903038;GO:0022408;GO:0030889;GO:0030888;GO:0002635;GO:0002823;GO:0002820;GO:0045623;GO:0043371;GO:0045622;GO:0043370;GO:0046639;GO:2000515;GO:2000514;GO:0045581;GO:0046636;GO:0045620;GO:1902106,regulation of alpha-beta T cell differentiation,1
0,1,3,61,GO:0046649;GO:0045321,leukocyte activation,1
0,1,3,5,GO:0046651;GO:0032943;GO:0070661,lymphocyte proliferation,1
0,1,3,37,GO:0046677,response to antibiotic,1
0,1,2,8,GO:0046685,response to arsenic-containing substance,1
0,1,5,5,GO:0046717,acid secretion,1
0,1,3,7,GO:0046755,viral budding,1
0,1,4,12,GO:0046782;GO:0050434;GO:0048524,positive regulation of viral process,1
0,1,3,10,GO:0046822,regulation of nucleocytoplasmic transport,1
0,1,2,12,GO:0046847,filopodium assembly,1
0,1,4,7,GO:0046886;GO:0032352;GO:0046885;GO:0032350,regulation of hormone metabolic process,1
0,1,3,6,GO:0046888,negative regulation of hormone secretion,1
0,1,2,13,GO:0046890,regulation of lipid biosynthetic process,1
0,1,3,5,GO:0046902;GO:0090559,regulation of membrane permeability,1
0,1,2,19,GO:0046916,cellular transition metal ion homeostasis,1
0,1,3,8,GO:0046928;GO:0051588,regulation of neurotransmitter transport,1
0,1,6,38,GO:0046942;GO:0015849,carboxylic acid transport,1
0,1,3,9,GO:0047496;GO:0099518;GO:0072383;GO:0072386,vesicle cytoskeletal trafficking,1
0,1,3,4,GO:0047497;GO:0034643;GO:0051654,establishment of mitochondrion localization,
0,1,3,25,GO:0048002;GO:0019882,antigen processing and presentation,1
0,1,5,7,GO:0048008,platelet-derived growth factor receptor signaling pathway,1
0,1,5,10,GO:0048009,insulin-like growth factor receptor signaling pathway,1
0,1,3,4,GO:0048010,vascular endothelial growth factor receptor signaling pathway,1
0,1,4,39,GO:0048011;GO:0038179,neurotrophin TRK receptor signaling pathway,1
0,1,5,17,GO:0048015;GO:0048017,inositol lipid-mediated signaling,1
0,1,5,15,GO:0048025;GO:0033119;GO:0050686;GO:1903312,negative regulation of mRNA metabolic process,1
0,1,4,4,GO:0048026;GO:0033120;GO:0050685,positive regulation of mRNA splicing,
0,1,6,9,GO:0048041;GO:0007045;GO:0034333,cell-substrate adherens junction assembly,1
0,1,2,8,GO:0048048,embryonic eye morphogenesis,1
0,1,4,6,GO:0048096;GO:0045815,positive regulation of gene expression,
0,1,2,7,GO:0048134;GO:0007294;GO:0030716,germarium-derived oocyte fate determination,1
0,1,3,6,GO:0048145,regulation of fibroblast proliferation,1
0,1,2,4,GO:0048147,negative regulation of fibroblast proliferation,1
0,1,3,20,GO:0048169;GO:0048168;GO:0048167,regulation of synaptic plasticity,1
0,1,6,8,GO:0048170,positive regulation of long-term neuronal synaptic plasticity,1
0,1,6,4,GO:0048205;GO:0048200,Golgi transport vesicle coating,1
0,1,4,7,GO:0048208,COPII vesicle coating,1
0,1,5,18,GO:0048211;GO:0035493;GO:0048280,vesicle fusion with Golgi apparatus,1
0,1,4,6,GO:0048251;GO:0085029,elastic fiber assembly,1
0,1,3,7,GO:0048259,regulation of receptor-mediated endocytosis,1
0,1,2,4,GO:0048260,positive regulation of receptor-mediated endocytosis,1
0,1,2,6,GO:0048264;GO:0035143;GO:0035141,determination of ventral identity,1
0,1,2,15,GO:0048265;GO:0033555,multicellular organismal response to stress,1
0,1,3,32,GO:0048278;GO:0140056;GO:0022406,membrane docking,1
0,1,2,14,GO:0048285,organelle fission,1
0,1,2,6,GO:0048286,lung alveolus development,1
0,1,2,5,GO:0048384,retinoic acid receptor signaling pathway,1
0,1,2,26,GO:0048469;GO:0021700,developmental maturation,1
0,1,4,20,GO:0048477;GO:0007292,female gamete generation,1
0,1,4,8,GO:0048484,enteric nervous system development,1
0,1,4,5,GO:0048485,sympathetic nervous system development,1
0,1,4,17,GO:0048489;GO:0097479;GO:0097480;GO:0099003,vesicle-mediated transport in synapse,1
0,1,3,16,GO:0048496,maintenance of animal organ identity,1
0,1,2,5,GO:0048505;GO:0040034,regulation of development,
0,1,1,52,GO:0048511,rhythmic process,1
0,1,2,15,GO:0048514,blood vessel morphogenesis,1
0,1,2,8,GO:0048525,negative regulation of viral process,1
0,1,5,7,GO:0048536,spleen development,1
0,1,2,11,GO:0048538,thymus development,1
0,1,4,4,GO:0048541;GO:0048537,mucosal-associated lymphoid tissue development,1
0,1,2,4,GO:0048546,digestive tract morphogenesis,1
0,1,2,5,GO:0048557,embryonic digestive tract morphogenesis,1
0,1,2,23,GO:0048562,embryonic organ morphogenesis,1
0,1,2,7,GO:0048565,digestive tract development,1
0,1,2,4,GO:0048580,regulation of post-embryonic development,1
0,1,2,18,GO:0048592;GO:0090596,sensory organ morphogenesis,1
0,1,6,4,GO:0048593,camera-type eye morphogenesis,1
0,1,4,4,GO:0048596,embryonic camera-type eye morphogenesis,1
0,1,2,6,GO:0048635,negative regulation of muscle organ development,1
0,1,2,16,GO:0048639,positive regulation of developmental growth,1
0,1,4,4,GO:0048661,positive regulation of smooth muscle cell proliferation,1
0,1,4,10,GO:0048678,response to axon injury,1
0,1,3,4,GO:0048701,embryonic cranial skeleton morphogenesis,1
0,1,5,5,GO:0048703;GO:0030878,thyroid gland development,1
0,1,2,8,GO:0048704,embryonic skeletal system morphogenesis,1
0,1,2,18,GO:0048705,skeletal system morphogenesis,1
0,1,2,9,GO:0048706,embryonic skeletal system development,1
0,1,4,5,GO:0048712,negative regulation of astrocyte differentiation,1
0,1,4,38,GO:0048732,gland development,1
0,1,2,9,GO:0048738,cardiac muscle tissue development,1
0,1,6,9,GO:0048739;GO:0048747,muscle fiber development,1
0,1,2,10,GO:0048745,smooth muscle tissue development,1
0,1,6,9,GO:0048749,compound eye development,1
0,1,2,18,GO:0048762;GO:0001837,mesenchymal cell differentiation,1
0,1,2,18,GO:0048771,tissue remodeling,1
0,1,2,9,GO:0048793,pronephros development,1
0,1,5,4,GO:0048800;GO:0035317;GO:0035316,non-sensory hair organization,1
0,1,4,4,GO:0048803;GO:0048805;GO:0048808;GO:0035126;GO:0090598,imaginal disc-derived male genitalia morphogenesis,1
0,1,2,9,GO:0048806,genitalia development,1
0,1,3,5,GO:0048839,inner ear development,1
0,1,3,4,GO:0048841;GO:1902667,regulation of axon extension involved in axon guidance,1
0,1,5,8,GO:0048844,artery morphogenesis,1
0,1,6,4,GO:0048846;GO:1902284,axon extension involved in axon guidance,1
0,1,3,5,GO:0048853,forebrain morphogenesis,1
0,1,2,11,GO:0048863,stem cell differentiation,1
0,1,4,8,GO:0048864,stem cell development,1
0,1,2,8,GO:0050673,epithelial cell proliferation,1
0,1,3,45,GO:0050678,regulation of epithelial cell proliferation,1
0,1,6,29,GO:0050679,positive regulation of epithelial cell proliferation,1
0,1,2,19,GO:0050680,negative regulation of epithelial cell proliferation,1
0,1,5,10,GO:0050690,regulation of defense response to virus by virus,1
0,1,3,9,GO:0050707;GO:0050715,regulation of cytokine secretion,1
0,1,2,48,GO:0050708;GO:0002791,regulation of peptide secretion,1
0,1,4,12,GO:0050709;GO:0002792;GO:0051224;GO:1904950,negative regulation of establishment of protein localization,1
0,1,4,5,GO:0050718;GO:0032731;GO:0050706;GO:0050716;GO:0032651;GO:0032732;GO:0050704;GO:0032652,positive regulation of interleukin-1 secretion,1
0,1,2,7,GO:0050730,regulation of peptidyl-tyrosine phosphorylation,1
0,1,2,5,GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,1
0,1,2,8,GO:0050766;GO:0050764,positive regulation of phagocytosis,1
0,1,2,64,GO:0050769;GO:0010720;GO:0051962,positive regulation of nervous system development,1
0,1,2,16,GO:0050772;GO:0010770,positive regulation of cell morphogenesis involved in differentiation,1
0,1,2,20,GO:0050777,negative regulation of immune response,1
0,1,2,24,GO:0050792;GO:0043903,regulation of symbiosis,
0,1,3,6,GO:0050795,regulation of behavior,1
0,1,4,17,GO:0050796,regulation of insulin secretion,1
0,1,3,6,GO:0050805,negative regulation of synaptic transmission,1
0,1,3,20,GO:0050806,positive regulation of synaptic transmission,1
0,1,3,4,GO:0050820,positive regulation of coagulation,1
0,1,2,8,GO:0050847,progesterone receptor signaling pathway,1
0,1,4,6,GO:0050848,regulation of calcium-mediated signaling,1
0,1,2,4,GO:0050850,positive regulation of calcium-mediated signaling,1
0,1,3,31,GO:0050852;GO:0050851;GO:0002429;GO:0002768,immune response-activating cell surface receptor signaling pathway,1
0,1,4,11,GO:0050856;GO:0050854,regulation of T cell receptor signaling pathway,1
0,1,5,43,GO:0050870;GO:0051251;GO:1903039;GO:0002696;GO:0050867;GO:0022409;GO:0045785,positive regulation of cell adhesion,1
0,1,2,4,GO:0050873,brown fat cell differentiation,1
0,1,3,72,GO:0050878,regulation of body fluid levels,1
0,1,2,21,GO:0050880;GO:0035150;GO:0003018,regulation of tube size,1
0,1,2,12,GO:0050885,neuromuscular process controlling balance,1
0,1,4,21,GO:0050900,leukocyte migration,1
0,1,2,18,GO:0050905,neuromuscular process,1
0,1,3,12,GO:0050906,detection of stimulus involved in sensory perception,1
0,1,4,22,GO:0050920,regulation of chemotaxis,1
0,1,2,4,GO:0050921,positive regulation of chemotaxis,1
0,1,2,6,GO:0050923;GO:0061364;GO:1902742;GO:0050925;GO:0050922,regulation of negative chemotaxis,1
0,1,5,5,GO:0050968;GO:0050907;GO:0050966;GO:0050955;GO:0050951,detection of chemical stimulus involved in sensory perception of pain,1
0,1,3,9,GO:0050974;GO:0050982,detection of mechanical stimulus,1
0,1,2,9,GO:0050994,regulation of lipid catabolic process,1
0,1,7,10,GO:0051000;GO:0032770;GO:0050999;GO:0032768,regulation of nitric-oxide synthase activity,1
0,1,2,4,GO:0051014,actin filament severing,1
0,1,2,14,GO:0051017;GO:0061572,actin filament bundle assembly,1
0,1,2,79,GO:0051046;GO:1903530,regulation of secretion,1
0,1,2,23,GO:0051047;GO:1903532,positive regulation of secretion,1
0,1,4,177,GO:0051049,regulation of transport,1
0,1,2,57,GO:0051050,positive regulation of transport,1
0,1,2,30,GO:0051051,negative regulation of transport,1
0,1,2,11,GO:0051084;GO:0006458,'de novo' posttranslational protein folding,1
0,1,2,6,GO:0051085;GO:0061077,chaperone-mediated protein folding,1
0,1,3,46,GO:0051091,positive regulation of DNA-binding transcription factor activity,1
0,1,2,26,GO:0051092,positive regulation of NF-kappaB transcription factor activity,1
0,1,2,10,GO:0051100,negative regulation of binding,1
0,1,2,15,GO:0051101,regulation of DNA binding,1
0,1,3,8,GO:0051103;GO:0006266,DNA ligation,1
0,1,5,83,GO:0051130,positive regulation of cellular component organization,1
0,1,5,7,GO:0051146,striated muscle cell differentiation,1
0,1,2,16,GO:0051147,regulation of muscle cell differentiation,1
0,1,2,6,GO:0051148,negative regulation of muscle cell differentiation,1
0,1,2,5,GO:0051149,positive regulation of muscle cell differentiation,1
0,1,3,6,GO:0051150,regulation of smooth muscle cell differentiation,1
0,1,4,4,GO:0051151,negative regulation of smooth muscle cell differentiation,1
0,1,4,6,GO:0051180;GO:0051181,cofactor transport,1
0,1,4,15,GO:0051216,cartilage development,1
0,1,3,17,GO:0051222;GO:1904951;GO:0050714;GO:0002793,positive regulation of peptide secretion,1
0,1,5,81,GO:0051223;GO:0070201;GO:0090087;GO:0032880,regulation of protein localization,1
0,1,2,16,GO:0051225,spindle assembly,1
0,1,6,14,GO:0051258,protein polymerization,1
0,1,2,47,GO:0051260,protein homooligomerization,1
0,1,2,25,GO:0051262,protein tetramerization,1
0,1,2,15,GO:0051289,protein homotetramerization,1
0,1,3,6,GO:0051298,centrosome duplication,1
0,1,2,10,GO:0051303;GO:0050000,establishment of chromosome localization,1
0,1,4,45,GO:0051345,positive regulation of hydrolase activity,1
0,1,2,9,GO:0051346,negative regulation of hydrolase activity,1
0,1,5,15,GO:0051353;GO:0051341,regulation of oxidoreductase activity,1
0,1,3,9,GO:0051382;GO:0051383;GO:0007079;GO:0051305;GO:0007080;GO:0051310,chromosome movement towards spindle pole,1
0,1,2,11,GO:0051384,response to glucocorticoid,1
0,1,2,4,GO:0051402,neuron apoptotic process,1
0,1,4,26,GO:0051403;GO:0031098,stress-activated MAPK cascade,1
0,1,-1,8,GO:0051436,obsolete negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,1
0,1,3,4,GO:0051438,regulation of ubiquitin-protein transferase activity,1
0,1,4,4,GO:0051457,maintenance of protein location in nucleus,1
0,1,2,9,GO:0051492;GO:0032231;GO:0110020,regulation of actin filament bundle assembly,1
0,1,7,20,GO:0051495;GO:1902905,positive regulation of cytoskeleton organization,1
0,1,2,4,GO:0051496,positive regulation of stress fiber assembly,1
0,1,3,11,GO:0051568;GO:0001555,histone H3-K4 methylation,1
0,1,2,31,GO:0051592,response to calcium ion,1
0,1,2,5,GO:0051597,response to methylmercury,1
0,1,4,14,GO:0051607,defense response to virus,1
0,1,2,5,GO:0051642;GO:0061842;GO:0051645,Golgi localization,1
0,1,2,26,GO:0051648;GO:0051650,vesicle localization,1
0,1,3,48,GO:0051656,establishment of organelle localization,1
0,1,3,50,GO:0051693;GO:0030835;GO:0030837;GO:0030834;GO:0051494;GO:1901880;GO:1902904;GO:1901879;GO:0043242;GO:0043244;GO:0032272;GO:0031333,negative regulation of cytoskeleton organization,1
0,1,2,22,GO:0051705,multi-organism behavior,1
0,1,2,13,GO:0051769,regulation of nitric-oxide synthase biosynthetic process,1
0,1,2,7,GO:0051770,positive regulation of nitric-oxide synthase biosynthetic process,1
0,1,2,6,GO:0051771,negative regulation of nitric-oxide synthase biosynthetic process,1
0,1,2,10,GO:0051784,negative regulation of nuclear division,1
0,1,4,7,GO:0051817,modification of morphology or physiology of other organism involved in symbiotic interaction,1
0,1,6,8,GO:0051823,regulation of synapse structural plasticity,1
0,1,2,12,GO:0051881,regulation of mitochondrial membrane potential,1
0,1,2,7,GO:0051896,regulation of protein kinase B signaling,1
0,1,2,4,GO:0051897,positive regulation of protein kinase B signaling,1
0,1,2,9,GO:0051924,regulation of calcium ion transport,1
0,1,2,5,GO:0051928,positive regulation of calcium ion transport,1
0,1,5,6,GO:0051930;GO:0051931,regulation of sensory perception of pain,1
0,1,2,4,GO:0051952,regulation of amine transport,1
0,1,4,18,GO:0051963,regulation of synapse assembly,1
0,1,5,6,GO:0051964,negative regulation of synapse assembly,1
0,1,2,5,GO:0051965,positive regulation of synapse assembly,1
0,1,3,8,GO:0051966,regulation of synaptic transmission,
0,1,5,6,GO:0051988,regulation of attachment of spindle microtubules to kinetochore,1
0,1,4,23,GO:0055001,muscle cell development,1
0,1,2,12,GO:0055002;GO:0055013,striated muscle cell development,1
0,1,6,6,GO:0055003;GO:0030239;GO:0045214;GO:0048769;GO:0030240,sarcomere organization,1
0,1,3,14,GO:0055006,cardiac cell development,1
0,1,5,20,GO:0055008;GO:0060415,muscle tissue morphogenesis,1
0,1,2,8,GO:0055010,ventricular cardiac muscle tissue morphogenesis,1
0,1,2,17,GO:0060021,roof of mouth development,1
0,1,2,5,GO:0060026,convergent extension,1
0,1,3,6,GO:0060037,pharyngeal system development,1
0,1,3,18,GO:0060041,retina development in camera-type eye,1
0,1,4,9,GO:0060045;GO:0055023;GO:0060043;GO:0055021;GO:0055025;GO:0060421;GO:0055024;GO:0060420;GO:0045844;GO:0048636;GO:1901863,positive regulation of striated muscle tissue development,1
0,1,2,6,GO:0060048,cardiac muscle contraction,1
0,1,2,8,GO:0060052,neurofilament cytoskeleton organization,1
0,1,4,5,GO:0060059,embryonic retina morphogenesis in camera-type eye,1
0,1,7,4,GO:0060071,Wnt signaling pathway,
0,1,2,6,GO:0060113;GO:0042490,mechanoreceptor differentiation,1
0,1,6,7,GO:0060122,inner ear receptor cell stereocilium organization,1
0,1,3,4,GO:0060174,limb bud formation,1
0,1,5,17,GO:0060253;GO:0060251;GO:0048715;GO:0048713;GO:2000974;GO:1905457;GO:2000973;GO:1901533;GO:1905456;GO:1901532;GO:0048711;GO:0045687;GO:0014015,regulation of oligodendrocyte differentiation,1
0,1,2,4,GO:0060291,long-term synaptic potentiation,1
0,1,4,6,GO:0060324;GO:0043584;GO:0060123,regulation of growth hormone secretion,1
0,1,3,16,GO:0060325,face morphogenesis,1
0,1,2,4,GO:0060327,cytoplasmic actin-based contraction involved in cell motility,1
0,1,6,4,GO:0060333,interferon-gamma-mediated signaling pathway,1
0,1,4,4,GO:0060334;GO:0060330,regulation of interferon-gamma-mediated signaling pathway,1
0,1,4,35,GO:0060341,regulation of cellular localization,1
0,1,4,12,GO:0060346;GO:0060343;GO:0030501;GO:0070169,bone trabecula formation,1
0,1,2,7,GO:0060348,bone development,1
0,1,2,5,GO:0060349;GO:0003401,bone morphogenesis,1
0,1,2,4,GO:0060351,cartilage development involved in endochondral bone morphogenesis,1
0,1,9,5,GO:0060402;GO:0060401,cytosolic calcium ion transport,1
0,1,3,7,GO:0060411,cardiac septum morphogenesis,1
0,1,3,6,GO:0060441;GO:0061304;GO:0061299,epithelial tube branching involved in lung morphogenesis,1
0,1,4,5,GO:0060444,branching involved in mammary gland duct morphogenesis,1
0,1,4,8,GO:0060445,branching involved in salivary gland morphogenesis,1
0,1,2,8,GO:0060484;GO:0060485,mesenchyme development,1
0,1,4,4,GO:0060487;GO:0060479,lung cell differentiation,1
0,1,2,5,GO:0060535;GO:0060536,trachea cartilage morphogenesis,1
0,1,4,50,GO:0060627,regulation of vesicle-mediated transport,1
0,1,3,7,GO:0060710;GO:0021871;GO:0072070;GO:0060993,chorio-allantoic fusion,1
0,1,2,5,GO:0060763,mammary duct terminal end bud growth,1
0,1,2,36,GO:0060828,regulation of canonical Wnt signaling pathway,1
0,1,2,4,GO:0060872,semicircular canal development,1
0,1,2,4,GO:0060948,cardiac vascular smooth muscle cell development,1
0,1,4,4,GO:0060968,regulation of gene silencing,1
0,1,2,4,GO:0060977,coronary vasculature morphogenesis,1
0,1,6,7,GO:0060997;GO:0097061;GO:0099173;GO:0106027;GO:0035641;GO:0045794;GO:2000969;GO:1900451;GO:2000311;GO:1900449;GO:0099601;GO:2000463;GO:0051835;GO:0051968;GO:0097107;GO:0097106;GO:0098698;GO:0099084;GO:2000822;GO:1903365;GO:0021773;GO:0021879,positive regulation of synapse structural plasticity,1
0,1,2,4,GO:0061014,positive regulation of mRNA catabolic process,1
0,1,3,5,GO:0061037;GO:0061035,regulation of cartilage development,1
0,1,7,4,GO:0061097,regulation of protein tyrosine kinase activity,1
0,1,2,7,GO:0061351,neural precursor cell proliferation,1
0,1,4,6,GO:0061640,cytoskeleton-dependent cytokinesis,1
0,1,2,10,GO:0061982,meiosis I cell cycle process,1
0,1,2,7,GO:0062014,negative regulation of small molecule metabolic process,1
0,1,3,4,GO:0070121,Kupffer's vesicle development,1
0,1,2,18,GO:0070206,protein trimerization,1
0,1,3,6,GO:0070207,protein homotrimerization,1
0,1,2,16,GO:0070208;GO:0051291,protein heterooligomerization,1
0,1,2,4,GO:0070213,protein auto-ADP-ribosylation,1
0,1,3,7,GO:0070286;GO:0060285;GO:0060287;GO:0003351;GO:0003341;GO:0060286,epithelial cilium movement involved in determination of left/right asymmetry,1
0,1,2,6,GO:0070293;GO:0003014,renal system process,1
0,1,5,4,GO:0070301;GO:0097237,cellular response to hydrogen peroxide,1
0,1,3,13,GO:0070374;GO:0070372,regulation of ERK1 and ERK2 cascade,1
0,1,5,26,GO:0070507,regulation of microtubule cytoskeleton organization,1
0,1,2,11,GO:0070509,calcium ion import,1
0,1,2,27,GO:0070534,protein K63-linked ubiquitination,1
0,1,2,8,GO:0070555,response to interleukin-1,1
0,1,2,4,GO:0070584,mitochondrion morphogenesis,1
0,1,4,5,GO:0070828,heterochromatin organization,1
0,1,7,11,GO:0070830;GO:0120192;GO:0120193,tight junction assembly,1
0,1,4,12,GO:0070979,protein K11-linked ubiquitination,1
0,1,8,9,GO:0071044;GO:0008334,histone mRNA metabolic process,1
0,1,6,15,GO:0071156,regulation of cell cycle arrest,1
0,1,6,4,GO:0071157,negative regulation of cell cycle arrest,1
0,1,7,13,GO:0071158;GO:2000134;GO:1902807,positive regulation of cell cycle arrest,1
0,1,2,4,GO:0071168;GO:0034502,protein localization to chromatin,1
0,1,2,6,GO:0071222,cellular response to lipopolysaccharide,1
0,1,2,14,GO:0071230,cellular response to amino acid stimulus,1
0,1,3,6,GO:0071236,cellular response to antibiotic,1
0,1,2,17,GO:0071248;GO:0071241,cellular response to inorganic substance,1
0,1,3,5,GO:0071277,cellular response to calcium ion,1
0,1,5,5,GO:0071287;GO:0010042;GO:0060992,response to fungicide,1
0,1,5,14,GO:0071300;GO:0032526,response to retinoic acid,1
0,1,2,9,GO:0071320;GO:0051591,response to cAMP,1
0,1,4,13,GO:0071345,cellular response to cytokine stimulus,1
0,1,5,15,GO:0071363;GO:0070848,cellular response to growth factor stimulus,1
0,1,5,11,GO:0071364;GO:0070849,cellular response to epidermal growth factor stimulus,1
0,1,2,13,GO:0071375;GO:1901653,cellular response to peptide hormone stimulus,1
0,1,6,4,GO:0071377;GO:0033762,cellular response to glucagon stimulus,1
0,1,2,16,GO:0071407,cellular response to organic cyclic compound,1
0,1,4,41,GO:0071417;GO:1901699,cellular response to organonitrogen compound,1
0,1,4,9,GO:0071456;GO:0036294;GO:0071453,cellular response to hypoxia,1
0,1,3,8,GO:0071479;GO:0071478,cellular response to radiation,1
0,1,2,4,GO:0071577,zinc ion transmembrane transport,1
0,1,3,18,GO:0071695,anatomical structure maturation,1
0,1,4,4,GO:0071709,membrane assembly,1
0,1,2,25,GO:0071901;GO:0006469;GO:0033673;GO:0051348,negative regulation of protein kinase activity,1
0,1,2,5,GO:0072078;GO:0061333;GO:0072088;GO:0072171,renal tubule morphogenesis,1
0,1,3,4,GO:0072079,nephron tubule formation,1
0,1,2,6,GO:0072089,stem cell proliferation,1
0,1,4,6,GO:0072132,mesenchyme morphogenesis,1
0,1,4,22,GO:0072175;GO:0001838,epithelial tube formation,1
0,1,2,8,GO:0072234;GO:0072080;GO:0072170;GO:0072243;GO:0061326;GO:0072009;GO:0072207,nephron tubule development,1
0,1,5,11,GO:0072300;GO:0072216;GO:0072298;GO:0090193;GO:0072215;GO:0090192,regulation of glomerulus development,1
0,1,2,26,GO:0072329,monocarboxylic acid catabolic process,1
0,1,4,14,GO:0072384,organelle transport along microtubule,1
0,1,5,5,GO:0072499,photoreceptor cell axon guidance,1
0,1,2,34,GO:0072525,pyridine-containing compound biosynthetic process,1
0,1,4,20,GO:0072527;GO:0006220,pyrimidine-containing compound metabolic process,1
0,1,2,14,GO:0072528;GO:0006221,pyrimidine-containing compound biosynthetic process,1
0,1,2,9,GO:0072529;GO:0046135;GO:0006213,pyrimidine-containing compound catabolic process,1
0,1,2,7,GO:0072595,maintenance of protein localization in organelle,1
0,1,3,13,GO:0072655;GO:0070585,protein localization to mitochondrion,1
0,1,4,5,GO:0085020,protein K6-linked ubiquitination,1
0,1,5,4,GO:0090022;GO:0071622;GO:1902622;GO:0002688,regulation of leukocyte chemotaxis,1
0,1,6,23,GO:0090068,positive regulation of cell cycle process,1
0,1,5,18,GO:0090090,negative regulation of canonical Wnt signaling pathway,1
0,1,3,41,GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,1
0,1,4,19,GO:0090100;GO:0030513,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,1
0,1,4,7,GO:0090103,cochlea morphogenesis,1
0,1,4,14,GO:0090162,establishment of epithelial cell polarity,1
0,1,3,6,GO:0090175,regulation of establishment of planar polarity,1
0,1,5,17,GO:0090184;GO:0090183,regulation of kidney development,1
0,1,2,4,GO:0090199;GO:2001233,regulation of release of cytochrome c from mitochondria,1
0,1,3,14,GO:0090208;GO:0090207,regulation of triglyceride metabolic process,1
0,1,3,6,GO:0090234;GO:0090230;GO:1902115;GO:0090169;GO:0090224,regulation of spindle organization,1
0,1,3,8,GO:0090257,regulation of muscle system process,1
0,1,2,17,GO:0090263,positive regulation of canonical Wnt signaling pathway,1
0,1,2,26,GO:0090276;GO:0046883,regulation of hormone secretion,1
0,1,5,6,GO:0090277;GO:0046887,positive regulation of hormone secretion,1
0,1,2,30,GO:0090305,nucleic acid phosphodiester bond hydrolysis,1
0,1,3,5,GO:0090307,mitotic spindle assembly,1
0,1,2,14,GO:0090329,regulation of DNA-dependent DNA replication,1
0,1,2,5,GO:0090342,regulation of cell aging,1
0,1,4,9,GO:0097039,protein linear polyubiquitination,1
0,1,5,7,GO:0097084,vascular smooth muscle cell development,1
0,1,3,7,GO:0097150,neuronal stem cell population maintenance,1
0,1,3,30,GO:0097164,ammonium ion metabolic process,1
0,1,2,4,GO:0097327,response to antineoplastic agent,1
0,1,3,4,GO:0097384,cellular lipid biosynthetic process,1
0,1,5,11,GO:0097746;GO:0035296,regulation of tube diameter,1
0,1,3,4,GO:0098764;GO:0098762,meiotic cell cycle phase,1
0,1,3,16,GO:0098813,nuclear chromosome segregation,1
0,1,3,9,GO:0098815;GO:0071625,vocalization behavior,1
0,1,2,5,GO:0098930,axonal transport,1
0,1,2,5,GO:0099120,socially cooperative development,1
0,1,6,18,GO:0099643,signal release from synapse,1
0,1,3,11,GO:0110110,positive regulation of animal organ morphogenesis,1
0,1,5,4,GO:0120034,positive regulation of plasma membrane bounded cell projection assembly,1
0,1,3,6,GO:1901068,guanosine-containing compound metabolic process,1
0,1,2,4,GO:1901070,guanosine-containing compound biosynthetic process,1
0,1,4,122,GO:1901137,carbohydrate derivative biosynthetic process,1
0,1,2,18,GO:1901570,fatty acid derivative biosynthetic process,1
0,1,2,8,GO:1901654,response to ketone,1
0,1,2,10,GO:1901661,quinone metabolic process,1
0,1,2,25,GO:1901991;GO:1901988,negative regulation of mitotic cell cycle phase transition,1
0,1,2,7,GO:1902275,regulation of chromatin organization,1
0,1,7,41,GO:1902600;GO:0098660;GO:0098662;GO:0098655,inorganic cation transmembrane transport,1
0,1,2,4,GO:1903008,organelle disassembly,1
0,1,3,9,GO:1903305,regulation of regulated secretory pathway,1
0,1,2,8,GO:1903313,positive regulation of mRNA metabolic process,1
0,1,2,6,GO:1903409,reactive oxygen species biosynthetic process,1
0,1,4,5,GO:1903510,mucopolysaccharide metabolic process,1
0,1,3,11,GO:1903522,regulation of blood circulation,1
0,1,5,8,GO:1903524,positive regulation of blood circulation,1
0,1,3,16,GO:1903531;GO:0051048,negative regulation of secretion by cell,1
0,1,2,25,GO:1903707,negative regulation of hemopoiesis,1
0,1,3,12,GO:1904064;GO:1904062;GO:0034765;GO:0034767;GO:0034764,positive regulation of transmembrane transport,1
0,1,6,7,GO:1905039;GO:0098656;GO:1903825,anion transmembrane transport,1
0,1,5,18,GO:1905330,regulation of morphogenesis of an epithelium,1
0,1,3,11,GO:1990542,mitochondrial transmembrane transport,1
0,1,2,15,GO:2000045;GO:1902806,regulation of G1/S transition of mitotic cell cycle,1
0,1,5,4,GO:2000107;GO:2000106,negative regulation of leukocyte apoptotic process,1
0,1,3,13,GO:2000241,regulation of reproductive process,1
0,1,4,5,GO:2000242,negative regulation of reproductive process,1
0,1,4,7,GO:2000273;GO:0010469,regulation of signaling receptor activity,1
0,1,5,16,GO:2000377,regulation of reactive oxygen species metabolic process,1
0,1,2,7,GO:2000379,positive regulation of reactive oxygen species metabolic process,1
0,1,3,4,GO:2000794,regulation of epithelial cell proliferation involved in lung morphogenesis,1
0,1,7,10,GO:2001251,negative regulation of chromosome organization,1
0,1,4,6,GO:2001259;GO:2001257;GO:0032414;GO:0032412,regulation of ion transmembrane transporter activity,1